Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	CD8 receptor binding	HLA-A HLA-B HLA-E HLA-G HLA-H	2.06e-08	9	224	5	GO:0042610
GeneOntologyMolecularFunction	TAP complex binding	HLA-A HLA-B HLA-E HLA-G HLA-H	2.06e-08	9	224	5	GO:0062061
GeneOntologyMolecularFunction	TAP1 binding	HLA-A HLA-B HLA-E HLA-G HLA-H	4.09e-08	10	224	5	GO:0046978
GeneOntologyMolecularFunction	TAP2 binding	HLA-A HLA-B HLA-E HLA-G HLA-H	4.09e-08	10	224	5	GO:0046979
GeneOntologyMolecularFunction	TAP binding	HLA-A HLA-B HLA-E HLA-G HLA-H	4.09e-08	10	224	5	GO:0046977
GeneOntologyMolecularFunction	beta-2-microglobulin binding	HLA-A HLA-B HLA-E HLA-G HLA-H	1.26e-07	12	224	5	GO:0030881
GeneOntologyMolecularFunction	natural killer cell lectin-like receptor binding	HLA-A HLA-B HLA-E HLA-G HLA-H	9.42e-07	17	224	5	GO:0046703
GeneOntologyMolecularFunction	T cell receptor binding	HLA-A HLA-B HLA-E HLA-G HLA-H	2.30e-06	20	224	5	GO:0042608
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-7 ERVK-21 ERVK-9 ASTL ERVK-19 ERVK-24	3.81e-06	38	224	6	GO:0070001
GeneOntologyMolecularFunction	MAP kinase kinase kinase activity	LRRK2 BRAF MAP3K19 RAF1 ARAF	1.12e-05	27	224	5	GO:0004709
GeneOntologyMolecularFunction	MHC class I protein binding	HLA-A HLA-B HLA-E HLA-G HLA-H	2.67e-05	32	224	5	GO:0042288
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-7 ERVK-21 ERVK-9 ERVK-19 ERVK-24	5.53e-05	37	224	5	GO:0004190
GeneOntologyMolecularFunction	14-3-3 protein binding	HLA-A HLA-B HLA-E HLA-G HLA-H	1.03e-04	42	224	5	GO:0071889
GeneOntologyMolecularFunction	calcium ion binding	CLGN ZZEF1 TENM2 SVEP1 CEMIP2 LRP8 HMCN2 BRAF LPCAT2 CANT1 USP32 ADGRE4P PLCB1 ASTN2 UNC13B HMCN1 CADPS VCAN LRP1 EPDR1 CDH2	1.13e-04	749	224	21	GO:0005509
GeneOntologyMolecularFunction	ATPase-coupled inorganic anion transmembrane transporter activity	ABCC1 ABCC5 ABCC6	1.58e-04	10	224	3	GO:0043225
GeneOntologyMolecularFunction	ABC-type transporter activity	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	2.17e-04	49	224	5	GO:0140359
GeneOntologyMolecularFunction	peptide antigen binding	HLA-A HLA-B HLA-E HLA-G HLA-H	2.17e-04	49	224	5	GO:0042605
GeneOntologyMolecularFunction	protein serine kinase activity	TRPM6 LRRK2 RIOK3 CDKL1 BRAF MAP3K19 RAF1 VRK1 KALRN ARAF MAPK4 MAPK9 ALPK2	2.46e-04	363	224	13	GO:0106310
GeneOntologyMolecularFunction	apolipoprotein receptor activity	ABCA7 LRP1	3.73e-04	3	224	2	GO:0030226
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	TRPM6 LRRK2 RIOK3 DGKH CDKL1 BRAF KHK MAP3K19 RAF1 VRK1 CAD KALRN ARAF IGF2R AGK MAPK4 MAPK9 ALPK2 EPHA8	4.23e-04	709	224	19	GO:0016773
GeneOntologyMolecularFunction	MHC protein binding	HLA-A HLA-B HLA-E HLA-G HLA-H	4.80e-04	58	224	5	GO:0042287
GeneOntologyMolecularFunction	modification-dependent protein binding	ZZEF1 SPIN1 SPIN2A SPIN2B ANK3 PRPF8 DNAJC2 EP300 SPIN3	5.49e-04	206	224	9	GO:0140030
GeneOntologyMolecularFunction	ABC-type xenobiotic transporter activity	ABCC1 ABCC5 ABCC6	5.74e-04	15	224	3	GO:0008559
GeneOntologyMolecularFunction	kinase activity	TRPM6 LRRK2 RIOK3 DGKH CDKL1 BRAF KHK MAP3K19 RAF1 VRK1 CAD KALRN ARAF IGF2R AGK MAPK4 MAPK9 ALPK2 EPHA8	1.03e-03	764	224	19	GO:0016301
GeneOntologyMolecularFunction	cell adhesion molecule binding	ITGA6 NFASC ITGAX TENM2 SVEP1 CEMIP2 PVR NECTIN1 ROBO3 FN1 ANK3 NRCAM NECTIN3 TNN CDH2 TNXB	1.24e-03	599	224	16	GO:0050839
GeneOntologyMolecularFunction	protein kinase activity	TRPM6 LRRK2 RIOK3 CDKL1 BRAF MAP3K19 RAF1 VRK1 CAD KALRN ARAF IGF2R MAPK4 MAPK9 ALPK2 EPHA8	1.26e-03	600	224	16	GO:0004672
GeneOntologyMolecularFunction	ATPase-coupled transmembrane transporter activity	ABCA7 ABCC1 ABCC5 ATP13A5 ABCC6 ABCC12	1.44e-03	109	224	6	GO:0042626
GeneOntologyMolecularFunction	protein serine/threonine kinase activity	TRPM6 LRRK2 RIOK3 CDKL1 BRAF MAP3K19 RAF1 VRK1 KALRN ARAF MAPK4 MAPK9 ALPK2	1.65e-03	446	224	13	GO:0004674
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TRPM6 LRRK2 RIOK3 DGKH ERVK-7 CDKL1 BRAF KHK POLN MAP3K19 RAF1 VRK1 CAD KALRN ARAF IGF2R AGK MAPK4 MAPK9 ALPK2 EPHA8	2.08e-03	938	224	21	GO:0016772
GeneOntologyMolecularFunction	collagen binding	ADGRG1 MRC2 FN1 TNXB PCOLCE	2.18e-03	81	224	5	GO:0005518
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent	HLA-A HLA-B HLA-E HLA-G HLA-H	7.36e-09	8	221	5	GO:0002485
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	HLA-A HLA-B HLA-E HLA-G HLA-H	5.35e-07	16	221	5	GO:0002486
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway	HLA-A HLA-B HLA-E HLA-G HLA-H	7.52e-07	17	221	5	GO:0002484
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class Ib	HLA-A HLA-B HLA-E HLA-G HLA-H	7.52e-07	17	221	5	GO:0002476
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class Ib	HLA-A HLA-B HLA-E HLA-G HLA-H	1.03e-06	18	221	5	GO:0002428
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-E HLA-G HLA-H	1.03e-06	18	221	5	GO:0042590
GeneOntologyBiologicalProcess	protection from natural killer cell mediated cytotoxicity	HLA-A HLA-B HLA-E HLA-G	1.55e-06	9	221	4	GO:0042270
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen via MHC class I	HLA-A HLA-B HLA-E HLA-G HLA-H	3.88e-06	23	221	5	GO:0019885
GeneOntologyBiologicalProcess	cell-cell adhesion	CPLANE2 IL15 HLA-A HLA-E VSIG4 HLA-G ITGA6 NFASC ITGAX TENM2 SVEP1 HMCN2 PVR NECTIN1 PKD1 ASTN2 ROBO3 SDK1 SDK2 ANK3 NRCAM FNDC3A NECTIN3 IGDCC4 HMCN1 RNASE10 CDH2 TNXB EP300	4.69e-06	1077	221	29	GO:0098609
GeneOntologyBiologicalProcess	positive regulation of T cell mediated cytotoxicity	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	5.37e-06	42	221	6	GO:0001916
GeneOntologyBiologicalProcess	homophilic cell adhesion via plasma membrane adhesion molecules	HMCN2 PVR NECTIN1 PKD1 ROBO3 SDK1 SDK2 NRCAM NECTIN3 HMCN1 CDH2	5.82e-06	187	221	11	GO:0007156
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous peptide antigen	HLA-A HLA-B HLA-E HLA-G HLA-H	6.02e-06	25	221	5	GO:0002483
GeneOntologyBiologicalProcess	antigen processing and presentation via MHC class Ib	HLA-A HLA-B HLA-E HLA-G HLA-H	6.02e-06	25	221	5	GO:0002475
GeneOntologyBiologicalProcess	neuron projection development	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ITGA6 BBS4 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 VPS13A ROBO3 SDK1 VRK1 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 RIMS1 MAPK9 CDH2 TNXB EP300 EPHA8	7.29e-06	1285	221	32	GO:0031175
GeneOntologyBiologicalProcess	protein retention in Golgi apparatus	VPS13C VPS13A VPS13D	1.19e-05	5	221	3	GO:0045053
GeneOntologyBiologicalProcess	regulation of T cell mediated cytotoxicity	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	2.13e-05	53	221	6	GO:0001914
GeneOntologyBiologicalProcess	antigen processing and presentation of endogenous antigen	HLA-A HLA-B HLA-E HLA-G HLA-H	2.15e-05	32	221	5	GO:0019883
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	CPLANE2 TENM2 HMCN2 PVR NECTIN1 PKD1 ROBO3 SDK1 SDK2 NRCAM NECTIN3 HMCN1 CDH2	3.54e-05	313	221	13	GO:0098742
GeneOntologyBiologicalProcess	neuron development	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ITGA6 BBS4 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 VPS13A ROBO3 CNGB1 SDK1 VRK1 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 RIMS1 MAPK9 CDH2 TNXB EP300 EPHA8	3.87e-05	1463	221	33	GO:0048666
GeneOntologyBiologicalProcess	regulation of plasma membrane bounded cell projection organization	HLA-A HLA-B TBC1D7 LRRK2 HLA-E HLA-G HLA-H ITGA6 BBS4 TENM2 CDKL1 LRP8 BRAF ROBO3 CEP97 FN1 NRCAM KALRN TNN LRP1 OCLN CDH2 EP300	4.20e-05	846	221	23	GO:0120035
GeneOntologyBiologicalProcess	regulation of cell projection organization	HLA-A HLA-B TBC1D7 LRRK2 HLA-E HLA-G HLA-H ITGA6 BBS4 TENM2 CDKL1 LRP8 BRAF ROBO3 CEP97 FN1 NRCAM KALRN TNN LRP1 OCLN CDH2 EP300	5.68e-05	863	221	23	GO:0031344
GeneOntologyBiologicalProcess	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	TENM2 PVR NECTIN1 NECTIN3 HMCN1 CDH2	5.77e-05	63	221	6	GO:0007157
GeneOntologyBiologicalProcess	clustering of voltage-gated sodium channels	NFASC ANK3 NRCAM	6.53e-05	8	221	3	GO:0045162
GeneOntologyBiologicalProcess	antigen processing and presentation of peptide antigen via MHC class I	HLA-A HLA-B HLA-E HLA-G HLA-H	7.39e-05	41	221	5	GO:0002474
GeneOntologyBiologicalProcess	T cell mediated cytotoxicity	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	1.05e-04	70	221	6	GO:0001913
GeneOntologyBiologicalProcess	positive regulation of synaptic vesicle priming	UNC13B RIMS1	1.14e-04	2	221	2	GO:0010808
GeneOntologyBiologicalProcess	axonogenesis	NFASC TENM2 HMCN2 BRAF NECTIN1 ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 CDH2 EP300 EPHA8	1.36e-04	566	221	17	GO:0007409
GeneOntologyBiologicalProcess	presynaptic dense core vesicle exocytosis	UNC13B CADPS RIMS1	1.38e-04	10	221	3	GO:0099525
GeneOntologyBiologicalProcess	positive regulation of T cell mediated immunity	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	1.43e-04	74	221	6	GO:0002711
GeneOntologyBiologicalProcess	neuron projection morphogenesis	LRRK2 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 VPS13A ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 RIMS1 CDH2 EP300 EPHA8	1.54e-04	802	221	21	GO:0048812
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous peptide antigen	HLA-A HLA-B HLA-E HLA-G HLA-H	1.59e-04	48	221	5	GO:0002478
GeneOntologyBiologicalProcess	maintenance of protein location in cell	VPS13C BBS4 VPS13A TNRC6A ANK3 VPS13D	1.65e-04	76	221	6	GO:0032507
GeneOntologyBiologicalProcess	positive regulation of leukocyte mediated cytotoxicity	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	2.05e-04	79	221	6	GO:0001912
GeneOntologyBiologicalProcess	plasma membrane bounded cell projection morphogenesis	LRRK2 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 VPS13A ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 RIMS1 CDH2 EP300 EPHA8	2.05e-04	819	221	21	GO:0120039
GeneOntologyBiologicalProcess	cell projection morphogenesis	LRRK2 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 VPS13A ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 RIMS1 CDH2 EP300 EPHA8	2.30e-04	826	221	21	GO:0048858
GeneOntologyBiologicalProcess	neuronal dense core vesicle exocytosis	UNC13B CADPS RIMS1	2.49e-04	12	221	3	GO:0099011
GeneOntologyBiologicalProcess	regulation of neuron projection development	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ITGA6 LRP8 BRAF ROBO3 FN1 NRCAM KALRN TNN LRP1 CDH2 EP300	3.39e-04	612	221	17	GO:0010975
GeneOntologyBiologicalProcess	positive regulation of cell killing	HLA-A HLA-B HLA-E HLA-G HLA-H PVR	3.69e-04	88	221	6	GO:0031343
GeneOntologyBiologicalProcess	antigen processing and presentation of exogenous antigen	HLA-A HLA-B HLA-E HLA-G HLA-H	3.90e-04	58	221	5	GO:0019884
GeneOntologyBiologicalProcess	cell morphogenesis involved in neuron differentiation	LRRK2 NFASC TENM2 LRP8 HMCN2 BRAF NECTIN1 ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 CDH2 EP300 EPHA8	4.65e-04	748	221	19	GO:0048667
GeneOntologyBiologicalProcess	dense core granule exocytosis	UNC13B CADPS RIMS1	5.02e-04	15	221	3	GO:1990504
GeneOntologyBiologicalProcess	face development	BBS4 BRAF RAF1 CHD7 EP300	5.72e-04	63	221	5	GO:0060324
GeneOntologyBiologicalProcess	axon development	NFASC TENM2 HMCN2 BRAF NECTIN1 ROBO3 WDR36 FN1 ANK3 NRCAM ATG7 KALRN TNN LRP1 CDH2 EP300 EPHA8	5.83e-04	642	221	17	GO:0061564
GeneOntologyCellularComponent	MHC class Ib protein complex	HLA-A HLA-B HLA-E HLA-G HLA-H	2.67e-09	7	222	5	GO:0032398
GeneOntologyCellularComponent	MHC class I protein complex	HLA-A HLA-B HLA-E HLA-G HLA-H	3.12e-08	10	222	5	GO:0042612
GeneOntologyCellularComponent	Golgi medial cisterna	MAN2A1 HLA-A HLA-B HLA-E HLA-G HLA-H	1.16e-07	23	222	6	GO:0005797
GeneOntologyCellularComponent	MHC class I peptide loading complex	HLA-A HLA-B HLA-E HLA-G HLA-H	2.39e-07	14	222	5	GO:0042824
GeneOntologyCellularComponent	endoplasmic reticulum exit site	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H MPPE1	2.73e-07	42	222	7	GO:0070971
GeneOntologyCellularComponent	cis-Golgi network membrane	HLA-A HLA-B HLA-E HLA-G HLA-H	7.20e-07	17	222	5	GO:0033106
GeneOntologyCellularComponent	MHC protein complex	HLA-A HLA-B HLA-E HLA-G HLA-H	7.08e-06	26	222	5	GO:0042611
GeneOntologyCellularComponent	lumenal side of endoplasmic reticulum membrane	HLA-A HLA-B HLA-E HLA-G HLA-H	3.23e-05	35	222	5	GO:0098553
GeneOntologyCellularComponent	cis-Golgi network	MAN2A1 HLA-A HLA-B HLA-E HLA-G HLA-H MPPE1	3.39e-05	85	222	7	GO:0005801
GeneOntologyCellularComponent	cell surface	IL15 HLA-A HLA-B HLA-E HLA-G HLA-H ITGA6 ZZEF1 ITGAX ABCA7 LRP8 MRC2 PVR PKD1 ADGRE4P SLC39A6 ANK3 NRCAM IGF2R PEBP1 TNN VCAN LRP1 TMEM102 OCLN LY9 CDH2	5.29e-05	1111	222	27	GO:0009986
GeneOntologyCellularComponent	lysosome	HLA-A HLA-B VPS13C TBC1D7 LRRK2 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 ANK3 AP1M2 TMEM25 CD300LD VCAN LRP1 CTBS EPDR1 OCLN RUBCN	5.65e-05	811	222	22	GO:0005764
GeneOntologyCellularComponent	lytic vacuole	HLA-A HLA-B VPS13C TBC1D7 LRRK2 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 ANK3 AP1M2 TMEM25 CD300LD VCAN LRP1 CTBS EPDR1 OCLN RUBCN	5.65e-05	811	222	22	GO:0000323
GeneOntologyCellularComponent	vesicle membrane	HLA-A HLA-B VPS13C LRRK2 HLA-E HLA-G HLA-H NFASC SLC30A4 ITGAX ABCA7 RBSN VPS13A PKD1 AP1M1 CNGB1 UNC13B AP1M2 ABCC5 ATP13A5 FNDC3A CEMIP RAB18 IGF2R MS4A3 CADPS SCG3 SNX25 LRP1 EPHA8	7.23e-05	1325	222	30	GO:0012506
GeneOntologyCellularComponent	Golgi stack	MAN2A1 HLA-A HLA-B HLA-E HLA-G HLA-H LPCAT2 CANT1 VRK1	9.19e-05	171	222	9	GO:0005795
GeneOntologyCellularComponent	cytoplasmic vesicle membrane	HLA-A HLA-B VPS13C LRRK2 HLA-E HLA-G HLA-H NFASC SLC30A4 ITGAX ABCA7 RBSN VPS13A PKD1 AP1M1 CNGB1 UNC13B AP1M2 ABCC5 ATP13A5 CEMIP RAB18 IGF2R MS4A3 CADPS SCG3 SNX25 LRP1 EPHA8	1.37e-04	1307	222	29	GO:0030659
GeneOntologyCellularComponent	lumenal side of membrane	HLA-A HLA-B HLA-E HLA-G HLA-H	1.52e-04	48	222	5	GO:0098576
GeneOntologyCellularComponent	Golgi apparatus subcompartment	MAN2A1 HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H LPCAT2 CANT1 AP1M1 CORO7 VRK1 AP1M2 IGF2R	2.93e-04	443	222	14	GO:0098791
GeneOntologyCellularComponent	vacuole	HLA-A HLA-B VPS13C TBC1D7 LRRK2 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 ANK3 AP1M2 TMEM25 CD300LD VCAN LRP1 CTBS EPDR1 OCLN RUBCN	3.04e-04	913	222	22	GO:0005773
GeneOntologyCellularComponent	lateral plasma membrane	PKD1 ABCC1 ANK3 ABCC6 OCLN SNTA1	3.97e-04	90	222	6	GO:0016328
GeneOntologyCellularComponent	lysosomal membrane	HLA-A HLA-B VPS13C TBC1D7 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 AP1M2 LRP1 OCLN	4.47e-04	462	222	14	GO:0005765
GeneOntologyCellularComponent	lytic vacuole membrane	HLA-A HLA-B VPS13C TBC1D7 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 AP1M2 LRP1 OCLN	4.47e-04	462	222	14	GO:0098852
GeneOntologyCellularComponent	coated vesicle	HLA-A HLA-B HLA-E HLA-G HLA-H F8 AP1M1 ASTN2 AP1M2 CEMIP IGF2R LRP1	4.95e-04	360	222	12	GO:0030135
GeneOntologyCellularComponent	coated vesicle membrane	HLA-A HLA-B HLA-E HLA-G HLA-H AP1M1 AP1M2 CEMIP IGF2R	5.05e-04	215	222	9	GO:0030662
GeneOntologyCellularComponent	ER to Golgi transport vesicle membrane	HLA-A HLA-B HLA-E HLA-G HLA-H	5.92e-04	64	222	5	GO:0012507
GeneOntologyCellularComponent	Golgi cisterna	MAN2A1 HLA-A HLA-B HLA-E HLA-G HLA-H CANT1	6.08e-04	135	222	7	GO:0031985
GeneOntologyCellularComponent	early endosome	HLA-A HLA-B HLA-E HLA-G HLA-H ABCA7 RBSN AP1M1 ASTN2 MIB2 IGF2R LRP1 RUBCN EPHA8	6.63e-04	481	222	14	GO:0005769
GeneOntologyCellularComponent	tenascin complex	TNN TNXB	6.64e-04	4	222	2	GO:0090733
GeneOntologyCellularComponent	endosome	IL15 HLA-A HLA-B VPS13C LRRK2 HLA-E HLA-G HLA-H DGKH SLC30A4 ABCA7 RBSN VPS13A AP1M1 ASTN2 ABCC5 ATP13A5 MIB2 TMEM25 CD300LD IGF2R SNX25 LRP1 RUBCN EPHA8	6.78e-04	1167	222	25	GO:0005768
GeneOntologyCellularComponent	Golgi membrane	MAN2A1 HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ABCA7 LPCAT2 USP32 PKD1 AP1M1 CORO7 AP1M2 FNDC3A IGF2R SLC35B4 DSEL	7.23e-04	721	222	18	GO:0000139
GeneOntologyCellularComponent	secretory granule membrane	HLA-B VPS13C HLA-H NFASC ITGAX AP1M1 RAB18 IGF2R MS4A3 CADPS SCG3	8.24e-04	329	222	11	GO:0030667
GeneOntologyCellularComponent	vacuolar membrane	HLA-A HLA-B VPS13C TBC1D7 HLA-E HLA-G HLA-H SLC30A4 VPS13A AP1M1 TECPR1 AP1M2 LRP1 OCLN	1.10e-03	507	222	14	GO:0005774
GeneOntologyCellularComponent	COPII-coated ER to Golgi transport vesicle	HLA-A HLA-B HLA-E HLA-G HLA-H F8	1.15e-03	110	222	6	GO:0030134
GeneOntologyCellularComponent	node of Ranvier	NFASC ANK3 NRCAM	1.18e-03	20	222	3	GO:0033268
GeneOntologyCellularComponent	transport vesicle membrane	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H AP1M1 UNC13B AP1M2 SCG3	1.21e-03	293	222	10	GO:0030658
GeneOntologyCellularComponent	axon	IMPA1 LRRK2 NFASC TENM2 LRP8 HMCN2 NECTIN1 VSTM5 ROBO3 CNGB1 UNC13B CAD ANK3 NRCAM ATG7 NECTIN3 SLC8A3 PEBP1 TNN LRP1	1.36e-03	891	222	20	GO:0030424
GeneOntologyCellularComponent	Golgi-associated vesicle	LRRK2 PKD1 AP1M1 CNGB1 AP1M2 IGF2R	1.38e-03	114	222	6	GO:0005798
GeneOntologyCellularComponent	apical junction complex	NFASC NECTIN1 ANK3 NECTIN3 FRMD4A OCLN MTDH	1.53e-03	158	222	7	GO:0043296
GeneOntologyCellularComponent	ciliary transition zone	CPLANE2 BBS4 CDKL1 KIAA1549 TCTN2	1.72e-03	81	222	5	GO:0035869
GeneOntologyCellularComponent	membrane raft	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ADGRG1 LRP8 SLC39A6 PPP2R1B CDH2	1.77e-03	362	222	11	GO:0045121
GeneOntologyCellularComponent	membrane microdomain	HLA-A HLA-B LRRK2 HLA-E HLA-G HLA-H ADGRG1 LRP8 SLC39A6 PPP2R1B CDH2	1.85e-03	364	222	11	GO:0098857
GeneOntologyCellularComponent	external encapsulating structure	ITGA6 TFIP11 SVEP1 FREM2 HMCN2 ADAMTS20 PZP FN1 PKHD1L1 HMCN1 TNN VCAN SERPINC1 CDH2 TNXB PCOLCE	1.86e-03	658	222	16	GO:0030312
GeneOntologyCellularComponent	phagocytic vesicle membrane	HLA-A HLA-B HLA-E HLA-G HLA-H	1.92e-03	83	222	5	GO:0030670
GeneOntologyCellularComponent	early endosome membrane	HLA-A HLA-B HLA-E HLA-G HLA-H ABCA7 RBSN EPHA8	1.99e-03	212	222	8	GO:0031901
GeneOntologyCellularComponent	endosome membrane	HLA-A HLA-B VPS13C HLA-E HLA-G HLA-H SLC30A4 ABCA7 RBSN VPS13A ABCC5 ATP13A5 IGF2R SNX25 EPHA8	2.03e-03	602	222	15	GO:0010008
GeneOntologyCellularComponent	axon initial segment	NFASC ANK3 NRCAM	3.52e-03	29	222	3	GO:0043194
GeneOntologyCellularComponent	protein complex involved in cell adhesion	ITGA6 ITGAX TNN TNXB	3.57e-03	59	222	4	GO:0098636
GeneOntologyCellularComponent	terminal bouton	LRRK2 CNGB1 UNC13B CAD TNN	3.61e-03	96	222	5	GO:0043195
GeneOntologyCellularComponent	synaptic membrane	TENM2 GPR179 CHRNB3 LRP8 NECTIN1 UNC13B ANK3 NRCAM NECTIN3 SLC8A3 LRP1 RIMS1 CDH2 SNTA1	3.94e-03	583	222	14	GO:0097060
GeneOntologyCellularComponent	ciliary membrane	BBS4 PKD1 CNGB1 BRWD1 TCTN2	3.94e-03	98	222	5	GO:0060170
GeneOntologyCellularComponent	Golgi-associated vesicle membrane	PKD1 AP1M1 CNGB1 AP1M2	4.03e-03	61	222	4	GO:0030660
GeneOntologyCellularComponent	postsynaptic membrane	TENM2 GPR179 CHRNB3 LRP8 ANK3 NRCAM NECTIN3 SLC8A3 LRP1 CDH2 SNTA1	4.17e-03	405	222	11	GO:0045211
GeneOntologyCellularComponent	extracellular matrix	ITGA6 TFIP11 SVEP1 FREM2 HMCN2 ADAMTS20 PZP FN1 HMCN1 TNN VCAN SERPINC1 CDH2 TNXB PCOLCE	4.52e-03	656	222	15	GO:0031012
GeneOntologyCellularComponent	collagen-containing extracellular matrix	ITGA6 FREM2 HMCN2 ADAMTS20 PZP FN1 HMCN1 TNN VCAN SERPINC1 CDH2 TNXB PCOLCE	4.53e-03	530	222	13	GO:0062023
GeneOntologyCellularComponent	dense core granule membrane	VPS13C CADPS	4.78e-03	10	222	2	GO:0032127
MousePheno	spinal cord inflammation	HLA-A HLA-B HLA-E HLA-G HLA-H	1.36e-08	8	170	5	MP:0030987
MousePheno	decreased immature NK cell number	HLA-B HLA-E HLA-G HLA-H	1.92e-05	14	170	4	MP:0013666
MousePheno	decreased mature NK cell number	HLA-B HLA-E HLA-G HLA-H	5.66e-05	18	170	4	MP:0013672
MousePheno	abnormal immature NK cell number	HLA-B HLA-E HLA-G HLA-H	7.10e-05	19	170	4	MP:0013665
MousePheno	abnormal immature NK cell morphology	HLA-B HLA-E HLA-G HLA-H	7.10e-05	19	170	4	MP:0013699
Domain	Ig-like_fold	HLA-A HLA-B HLA-E VSIG4 HLA-G HLA-H NFASC FNDC1 HMCN2 PVR NECTIN1 ASTN2 VSTM5 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A NECTIN3 PKHD1L1 IGDCC4 TMEM25 CD300LD HMCN1 IGHE TNN VCAN TGM7 LY9 TNXB ALPK2 EPHA8	3.95e-13	706	218	35	IPR013783
Domain	-	HLA-A HLA-B HLA-E VSIG4 HLA-G NFASC FNDC1 PVR NECTIN1 ASTN2 VSTM5 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A NECTIN3 PKHD1L1 IGDCC4 TMEM25 CD300LD HMCN1 TNN VCAN TGM7 LY9 TNXB ALPK2 EPHA8	9.11e-12	663	218	32	2.60.40.10
Domain	Ig-like_dom	HLA-A HLA-B HLA-E VSIG4 HLA-G HLA-H NFASC HMCN2 PVR NECTIN1 VSTM5 ROBO3 SDK1 SDK2 NRCAM KALRN NECTIN3 IGDCC4 TMEM25 CD300LD HMCN1 IGHE VCAN LY9 ALPK2	1.14e-09	503	218	25	IPR007110
Domain	IG_LIKE	HLA-A HLA-B HLA-E VSIG4 HLA-G HLA-H NFASC HMCN2 PVR NECTIN1 ROBO3 SDK1 SDK2 NRCAM KALRN NECTIN3 IGDCC4 TMEM25 CD300LD HMCN1 IGHE VCAN LY9 ALPK2	3.48e-09	491	218	24	PS50835
Domain	FN3	NFASC FNDC1 ASTN2 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A IGDCC4 TNN TNXB EPHA8	4.75e-09	185	218	15	SM00060
Domain	fn3	NFASC FNDC1 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A IGDCC4 TNN TNXB EPHA8	6.91e-09	162	218	14	PF00041
Domain	FN3	NFASC FNDC1 ASTN2 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A IGDCC4 TNN TNXB EPHA8	1.28e-08	199	218	15	PS50853
Domain	FN3_dom	NFASC FNDC1 ASTN2 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A IGDCC4 TNN TNXB EPHA8	2.48e-08	209	218	15	IPR003961
Domain	SPIN/Ssty	SPIN1 SPIN2A SPIN2B SPIN3	8.95e-08	5	218	4	IPR003671
Domain	Spin-Ssty	SPIN1 SPIN2A SPIN2B SPIN3	8.95e-08	5	218	4	PF02513
Domain	MHC_I_a_C	HLA-A HLA-B HLA-E HLA-H	2.66e-07	6	218	4	IPR010579
Domain	MHC_I_C	HLA-A HLA-B HLA-E HLA-H	2.66e-07	6	218	4	PF06623
Domain	VPS13	VPS13C VPS13A VPS13D	1.57e-06	3	218	3	IPR026847
Domain	VPS13_mid_rpt	VPS13C VPS13A VPS13D	1.57e-06	3	218	3	PF16910
Domain	VPS13	VPS13C VPS13A VPS13D	1.57e-06	3	218	3	PF16908
Domain	VPS13_N2	VPS13C VPS13A VPS13D	1.57e-06	3	218	3	IPR031646
Domain	VPS13_mid_rpt	VPS13C VPS13A VPS13D	1.57e-06	3	218	3	IPR031642
Domain	IG	VSIG4 NFASC HMCN2 PVR NECTIN1 VSTM5 ROBO3 SDK1 SDK2 NRCAM KALRN NECTIN3 IGDCC4 CD300LD HMCN1 VCAN LY9 ALPK2	2.38e-06	421	218	18	SM00409
Domain	Ig_sub	VSIG4 NFASC HMCN2 PVR NECTIN1 VSTM5 ROBO3 SDK1 SDK2 NRCAM KALRN NECTIN3 IGDCC4 CD300LD HMCN1 VCAN LY9 ALPK2	2.38e-06	421	218	18	IPR003599
Domain	MHC_I	HLA-A HLA-B HLA-E HLA-G HLA-H	3.62e-06	21	218	5	PF00129
Domain	MHC_I_a_a1/a2	HLA-A HLA-B HLA-E HLA-G HLA-H	3.62e-06	21	218	5	IPR001039
Domain	Ig/MHC_CS	HLA-A HLA-B HLA-E HLA-G HLA-H NRCAM IGHE	4.86e-06	58	218	7	IPR003006
Domain	IG_MHC	HLA-A HLA-B HLA-E HLA-G HLA-H NRCAM IGHE	6.12e-06	60	218	7	PS00290
Domain	SHR-BD	VPS13C VPS13A VPS13D	6.22e-06	4	218	3	IPR009543
Domain	G8_domain	CEMIP2 PKHD1L1 CEMIP	6.22e-06	4	218	3	IPR019316
Domain	G8	CEMIP2 PKHD1L1 CEMIP	6.22e-06	4	218	3	PS51484
Domain	G8	CEMIP2 PKHD1L1 CEMIP	6.22e-06	4	218	3	SM01225
Domain	G8	CEMIP2 PKHD1L1 CEMIP	6.22e-06	4	218	3	PF10162
Domain	VPS13_C	VPS13C VPS13A VPS13D	6.22e-06	4	218	3	PF16909
Domain	VPS13_C	VPS13C VPS13A VPS13D	6.22e-06	4	218	3	IPR031645
Domain	SHR-BD	VPS13C VPS13A VPS13D	6.22e-06	4	218	3	PF06650
Domain	Ig_I-set	VSIG4 NFASC HMCN2 ROBO3 SDK1 SDK2 NRCAM KALRN IGDCC4 HMCN1 ALPK2	1.49e-05	190	218	11	IPR013098
Domain	I-set	VSIG4 NFASC HMCN2 ROBO3 SDK1 SDK2 NRCAM KALRN IGDCC4 HMCN1 ALPK2	1.49e-05	190	218	11	PF07679
Domain	IGc2	VSIG4 NFASC HMCN2 NECTIN1 ROBO3 SDK1 SDK2 NRCAM KALRN IGDCC4 HMCN1 ALPK2	2.15e-05	235	218	12	SM00408
Domain	EGF_3	TENM2 SVEP1 LRP8 HMCN2 ADGRE4P ASTN2 HMCN1 ATRNL1 TNN VCAN LRP1 TNXB	2.15e-05	235	218	12	PS50026
Domain	Ig_sub2	VSIG4 NFASC HMCN2 NECTIN1 ROBO3 SDK1 SDK2 NRCAM KALRN IGDCC4 HMCN1 ALPK2	2.15e-05	235	218	12	IPR003598
Domain	RBD	BRAF RAF1 ARAF	3.06e-05	6	218	3	PF02196
Domain	C1-set	HLA-A HLA-B HLA-E HLA-G HLA-H IGHE	3.82e-05	54	218	6	PF07654
Domain	IGc1	HLA-A HLA-B HLA-E HLA-G HLA-H IGHE	4.71e-05	56	218	6	SM00407
Domain	EGF_1	TENM2 SVEP1 LRP8 HMCN2 ASTN2 FN1 HMCN1 ATRNL1 TNN VCAN LRP1 TNXB	4.78e-05	255	218	12	PS00022
Domain	RBD	BRAF RAF1 ARAF	5.30e-05	7	218	3	SM00455
Domain	RBD_dom	BRAF RAF1 ARAF	5.30e-05	7	218	3	IPR003116
Domain	RBD	BRAF RAF1 ARAF	5.30e-05	7	218	3	PS50898
Domain	Ig_C1-set	HLA-A HLA-B HLA-E HLA-G HLA-H IGHE	5.76e-05	58	218	6	IPR003597
Domain	EGF-like_CS	TENM2 SVEP1 LRP8 HMCN2 FN1 HMCN1 ATRNL1 TNN VCAN LRP1 TNXB EPHA8	5.98e-05	261	218	12	IPR013032
Domain	EGF_2	TENM2 SVEP1 LRP8 HMCN2 ASTN2 HMCN1 ATRNL1 TNN VCAN LRP1 TNXB EPHA8	6.92e-05	265	218	12	PS01186
Domain	Chorein_N	VPS13C VPS13A VPS13D	8.41e-05	8	218	3	PF12624
Domain	Pectin_lyase_fold/virulence	CEMIP2 PKHD1L1 CEMIP	8.41e-05	8	218	3	IPR011050
Domain	VPS13_N	VPS13C VPS13A VPS13D	8.41e-05	8	218	3	IPR026854
Domain	EGF	TENM2 SVEP1 GPR179 LRP8 ADGRE4P HMCN1 ATRNL1 TNN VCAN LRP1 TNXB	1.04e-04	235	218	11	SM00181
Domain	EGF-like_Ca-bd_dom	TENM2 SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 VCAN LRP1	1.05e-04	124	218	8	IPR001881
Domain	ABC_transporter_CS	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	1.24e-04	42	218	5	IPR017871
Domain	SPIN-2	SPIN2A SPIN2B	1.36e-04	2	218	2	IPR029564
Domain	Hyd_WA	TECPR2 TECPR1	1.36e-04	2	218	2	PF06462
Domain	-	HLA-A HLA-B HLA-E HLA-G	1.60e-04	24	218	4	3.30.500.10
Domain	ABC_membrane	ABCC1 ABCC5 ABCC6 ABCC12	1.60e-04	24	218	4	PF00664
Domain	MHC_I-like_Ag-recog	HLA-A HLA-B HLA-E HLA-G	1.60e-04	24	218	4	IPR011161
Domain	EGF_CA	SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 VCAN LRP1	1.61e-04	99	218	7	PS01187
Domain	ASX_HYDROXYL	SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 VCAN LRP1	1.71e-04	100	218	7	PS00010
Domain	EGF-like_dom	TENM2 SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 ATRNL1 TNN VCAN LRP1 TNXB	1.72e-04	249	218	11	IPR000742
Domain	ABC_tran	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	2.36e-04	48	218	5	PF00005
Domain	ABC_TRANSPORTER_2	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	2.36e-04	48	218	5	PS50893
Domain	EGF-type_Asp/Asn_hydroxyl_site	SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 VCAN LRP1	2.46e-04	106	218	7	IPR000152
Domain	ABC_TRANSPORTER_1	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	2.60e-04	49	218	5	PS00211
Domain	ABC_transporter-like	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	2.86e-04	50	218	5	IPR003439
Domain	ABC_TM1F	ABCC1 ABCC5 ABCC6 ABCC12	2.97e-04	28	218	4	PS50929
Domain	ABC1_TM_dom	ABCC1 ABCC5 ABCC6 ABCC12	2.97e-04	28	218	4	IPR011527
Domain	TECPR	TECPR2 TECPR1	4.04e-04	3	218	2	SM00706
Domain	Beta-propeller_rpt_TECPR	TECPR2 TECPR1	4.04e-04	3	218	2	IPR006624
Domain	-	MRC2 FN1 IGF2R	4.11e-04	13	218	3	2.10.10.10
Domain	VWA	ITGAX SVEP1 INTS14 HMCN2 VWA7 HMCN1	4.50e-04	84	218	6	SM00327
Domain	Growth_fac_rcpt_	SVEP1 GPR179 LRP8 HMCN2 HMCN1 TNN LRP1 TNXB	5.01e-04	156	218	8	IPR009030
Domain	EGF_CA	SVEP1 LRP8 HMCN2 ADGRE4P HMCN1 LRP1	5.10e-04	86	218	6	PF07645
Domain	FN_type2_col-bd	MRC2 FN1 IGF2R	5.19e-04	14	218	3	IPR000562
Domain	FN2_2	MRC2 FN1 IGF2R	5.19e-04	14	218	3	PS51092
Domain	FN2_1	MRC2 FN1 IGF2R	5.19e-04	14	218	3	PS00023
Domain	fn2	MRC2 FN1 IGF2R	5.19e-04	14	218	3	PF00040
Domain	FN2	MRC2 FN1 IGF2R	5.19e-04	14	218	3	SM00059
Domain	C1_1	DGKH BRAF UNC13B RAF1 ARAF	5.29e-04	57	218	5	PF00130
Domain	EGF_CA	TENM2 SVEP1 LRP8 HMCN2 HMCN1 VCAN LRP1	5.77e-04	122	218	7	SM00179
Domain	Neurofascin/L1/NrCAM_C	NFASC NRCAM	8.01e-04	4	218	2	IPR026966
Domain	G2F	HMCN2 HMCN1	8.01e-04	4	218	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	8.01e-04	4	218	2	PS50993
Domain	GFP	HMCN2 HMCN1	8.01e-04	4	218	2	IPR009017
Domain	Bravo_FIGEY	NFASC NRCAM	8.01e-04	4	218	2	PF13882
Domain	Multidrug-R_assoc	ABCC1 ABCC6	8.01e-04	4	218	2	IPR005292
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	8.01e-04	4	218	2	IPR006605
Domain	ZF_DAG_PE_1	DGKH BRAF UNC13B RAF1 ARAF	9.02e-04	64	218	5	PS00479
Domain	ZF_DAG_PE_2	DGKH BRAF UNC13B RAF1 ARAF	9.02e-04	64	218	5	PS50081
Domain	EGF_Ca-bd_CS	SVEP1 LRP8 HMCN2 HMCN1 VCAN LRP1	9.65e-04	97	218	6	IPR018097
Domain	C1	DGKH BRAF UNC13B RAF1 ARAF	9.68e-04	65	218	5	SM00109
Domain	MHC_I/II-like_Ag-recog	HLA-A HLA-B HLA-E HLA-G	9.76e-04	38	218	4	IPR011162
Domain	PE/DAG-bd	DGKH BRAF UNC13B RAF1 ARAF	1.04e-03	66	218	5	IPR002219
Domain	VWF_A	ITGAX SVEP1 INTS14 HMCN2 VWA7 HMCN1	1.07e-03	99	218	6	IPR002035
Domain	ZF_ZZ_2	ZZEF1 MIB2 EP300	1.12e-03	18	218	3	PS50135
Domain	ZF_ZZ_1	ZZEF1 MIB2 EP300	1.12e-03	18	218	3	PS01357
Domain	ZZ	ZZEF1 MIB2 EP300	1.12e-03	18	218	3	PF00569
Domain	C2-set_2	PVR NECTIN1 NECTIN3 TMEM25	1.30e-03	41	218	4	PF08205
Domain	CD80_C2-set	PVR NECTIN1 NECTIN3 TMEM25	1.30e-03	41	218	4	IPR013162
Domain	Znf_ZZ	ZZEF1 MIB2 EP300	1.32e-03	19	218	3	IPR000433
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	HLA-A HLA-B HLA-E HLA-G ITGA6 NFASC PVR NECTIN1 NRCAM NECTIN3 VCAN OCLN CDH2	8.03e-10	133	142	13	M16476
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-E HLA-G HLA-H	1.18e-08	9	142	5	MM14527
Pathway	KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-E HLA-G	1.46e-07	6	142	4	M47468
Pathway	REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS	BRAF RAF1 FN1 ATG7 KIAA1549 ARAF PEBP1 AGK	2.70e-07	65	142	8	M38994
Pathway	KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-E HLA-G	3.37e-07	7	142	4	M47582
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-E HLA-G	3.37e-07	7	142	4	M47530
Pathway	REACTOME_ER_PHAGOSOME_PATHWAY	HLA-A HLA-B HLA-E HLA-G HLA-H	7.45e-07	18	142	5	MM14525
Pathway	BIOCARTA_CTL_PATHWAY	HLA-A HLA-B HLA-E HLA-G HLA-H	1.33e-06	20	142	5	MM1374
Pathway	REACTOME_ONCOGENIC_MAPK_SIGNALING	BRAF RAF1 FN1 ATG7 KIAA1549 ARAF PEBP1 AGK	1.65e-06	82	142	8	M27626
Pathway	REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY	HLA-A HLA-B HLA-E HLA-G	3.08e-06	11	142	4	M525
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-E HLA-G HLA-H	4.37e-06	25	142	5	MM15713
Pathway	BIOCARTA_NKCELLS_PATHWAY	HLA-A HLA-B HLA-E HLA-G HLA-H	4.37e-06	25	142	5	MM1465
Pathway	KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES	HLA-A HLA-B HLA-E HLA-G	4.59e-06	12	142	4	M47529
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	PVR NECTIN1 SDK1 SDK2 NECTIN3 CDH2	8.14e-06	48	142	6	MM15069
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ITGA6 PVR NECTIN1 SDK1 SDK2 NECTIN3 CDH2	8.49e-06	73	142	7	MM15126
Pathway	WP_FOCAL_ADHESION	ITGA6 ITGAX BRAF RAF1 FN1 ARAF TNN MAPK4 MAPK9 TNXB	1.94e-05	187	142	10	MM15913
Pathway	REACTOME_CELL_JUNCTION_ORGANIZATION	ITGA6 PVR NECTIN1 TNRC6A SDK1 SDK2 NECTIN3 CDH2	2.35e-05	117	142	8	M19248
Pathway	REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	PVR NECTIN1 TNRC6A SDK1 SDK2 NECTIN3 CDH2	3.38e-05	90	142	7	M820
Pathway	REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION	PVR NECTIN1 NECTIN3	3.40e-05	7	142	3	M27333
Pathway	REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION	PVR NECTIN1 NECTIN3	3.40e-05	7	142	3	MM15068
Pathway	KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY	BRAF PLCB1 RAF1 ARAF	3.40e-05	19	142	4	M47596
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	BRAF RAF1 FN1 ARAF PEBP1	4.22e-05	39	142	5	MM15272
Pathway	REACTOME_MAP2K_AND_MAPK_ACTIVATION	BRAF RAF1 FN1 ARAF PEBP1	4.79e-05	40	142	5	M27557
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ITGA6 PVR NECTIN1 SDK1 SDK2 NECTIN3 CDH2	5.12e-05	96	142	7	MM14592
Pathway	REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS	BRAF RAF1 ARAF	5.40e-05	8	142	3	M38999
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE	BRAF RAF1 ARAF	5.40e-05	8	142	3	M47933
Pathway	REACTOME_INTERFERON_GAMMA_SIGNALING	HLA-A HLA-B HLA-E HLA-G HLA-H RAF1 PIAS1	5.85e-05	98	142	7	M965
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	BRAF RAF1 ARAF PPP2R1B PEBP1	6.09e-05	42	142	5	MM15274
Pathway	REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY	BRAF RAF1 ARAF PPP2R1B PEBP1	6.84e-05	43	142	5	M27560
Pathway	KEGG_ABC_TRANSPORTERS	ABCA7 ABCC1 ABCC5 ABCC6 ABCC12	7.65e-05	44	142	5	M11911
Pathway	REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS	BRAF RAF1 FN1 ARAF PEBP1	8.54e-05	45	142	5	M27623
Pathway	REACTOME_ECM_PROTEOGLYCANS	ITGAX FN1 TNN VCAN TNXB	1.05e-04	47	142	5	MM14925
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	1.14e-04	10	142	3	M47374
Pathway	KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	1.14e-04	10	142	3	M47420
Pathway	KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	1.14e-04	10	142	3	M47735
Pathway	REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION	HLA-A AP1M1 AP1M2	1.14e-04	10	142	3	M17019
Pathway	REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	HLA-A HLA-B HLA-E HLA-G HLA-H MRC2	1.15e-04	76	142	6	MM14526
Pathway	KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	1.56e-04	11	142	3	M47370
Pathway	KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	1.56e-04	11	142	3	M47371
Pathway	REACTOME_CELL_CELL_COMMUNICATION	ITGA6 PVR NECTIN1 TNRC6A SDK1 SDK2 NECTIN3 CDH2	1.72e-04	155	142	8	M522
Pathway	REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	HLA-A HLA-B HLA-E HLA-G	1.93e-04	29	142	4	M1062
Pathway	REACTOME_DAP12_INTERACTIONS	HLA-A HLA-B HLA-E HLA-G HLA-H	2.06e-04	54	142	5	MM14871
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	2.06e-04	12	142	3	M47369
Pathway	KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	2.06e-04	12	142	3	M47815
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	2.06e-04	12	142	3	M47597
Pathway	KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	2.66e-04	13	142	3	M47589
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	PVR NECTIN1 TNRC6A NECTIN3 CDH2	2.88e-04	58	142	5	M11980
Pathway	KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47364
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47365
Pathway	KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47366
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47378
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47383
Pathway	KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47384
Pathway	KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	3.36e-04	14	142	3	M47488
Pathway	REACTOME_RAF_ACTIVATION	BRAF RAF1 ARAF PPP2R1B	3.62e-04	34	142	4	M27556
Pathway	REACTOME_RAF_ACTIVATION	BRAF RAF1 ARAF PPP2R1B	4.05e-04	35	142	4	MM15271
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47367
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47375
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47382
Pathway	KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47380
Pathway	KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47592
Pathway	KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47593
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47640
Pathway	KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47485
Pathway	KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47473
Pathway	KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47474
Pathway	KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47480
Pathway	KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47495
Pathway	KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47496
Pathway	KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47497
Pathway	KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47472
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47535
Pathway	KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	4.17e-04	15	142	3	M47531
Pathway	KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	HLA-A HLA-B HLA-E HLA-G BRAF RAF1 ARAF	4.70e-04	137	142	7	M5669
Pathway	KEGG_ALLOGRAFT_REJECTION	HLA-A HLA-B HLA-E HLA-G	5.03e-04	37	142	4	M18615
Pathway	KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47363
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47373
Pathway	KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47381
Pathway	KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47804
Pathway	KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47801
Pathway	KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47682
Pathway	KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	5.09e-04	16	142	3	M47483
Pathway	WP_INTEGRINMEDIATED_CELL_ADHESION	ITGA6 ITGAX BRAF RAF1 ARAF MAPK4	5.73e-04	102	142	6	MM15830
Pathway	WP_INTEGRINMEDIATED_CELL_ADHESION	ITGA6 ITGAX BRAF RAF1 ARAF MAPK4	5.73e-04	102	142	6	M39577
Pathway	KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	6.14e-04	17	142	3	M47376
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY	BRAF RAF1 ARAF	6.14e-04	17	142	3	M47684
Pathway	REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS	PVR NECTIN1 NECTIN3 CDH2	6.81e-04	40	142	4	MM15060
Pathway	KEGG_LONG_TERM_DEPRESSION	BRAF PLCB1 RAF1 ARAF PPP2R1B	6.92e-04	70	142	5	M8232
Pathway	KEGG_LONG_TERM_POTENTIATION	BRAF PLCB1 RAF1 ARAF EP300	6.92e-04	70	142	5	M3115
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH11 HLA-A HLA-B HLA-E HLA-G	6.92e-04	70	142	5	M12294
Pathway	WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS	BRAF RAF1 ARAF	7.31e-04	18	142	3	M39737
Pathway	KEGG_GRAFT_VERSUS_HOST_DISEASE	HLA-A HLA-B HLA-E HLA-G	7.48e-04	41	142	4	M13519
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	ANK3 MAPK4 MAPK9 CDH2	8.21e-04	42	142	4	M39703
Pathway	WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS	ANK3 MAPK4 MAPK9 CDH2	8.21e-04	42	142	4	MM15822
Pathway	KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY	BRAF RAF1 ARAF	8.61e-04	19	142	3	M47793
Pathway	KEGG_TYPE_I_DIABETES_MELLITUS	HLA-A HLA-B HLA-E HLA-G	8.98e-04	43	142	4	M12617
Pathway	REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT	ABCC5 CEMIP	9.88e-04	5	142	2	M27144
Pathway	REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT	ABCC5 CEMIP	9.88e-04	5	142	2	MM14865
Pathway	REACTOME_ECM_PROTEOGLYCANS	ITGAX FN1 TNN VCAN TNXB	1.01e-03	76	142	5	M27219
Pathway	REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.13e-03	78	142	5	M973
Pubmed	The NF-κB1 transcription factor prevents the intrathymic development of CD8 T cells with memory properties.	IL15 HLA-A HLA-B HLA-E HLA-G HLA-H	1.41e-11	10	225	6	22124325
Pubmed	Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells.	IL15 HLA-A HLA-B HLA-E HLA-G HLA-H	1.41e-11	10	225	6	12070281
Pubmed	IL-7 is critical for homeostatic proliferation and survival of naive T cells.	IL15 HLA-A HLA-B HLA-E HLA-G HLA-H	3.08e-11	11	225	6	11447288
Pubmed	CD137 stimulation delivers an antigen-independent growth signal for T lymphocytes with memory phenotype.	IL15 HLA-A HLA-B HLA-E HLA-G HLA-H	3.08e-11	11	225	6	17244673
Pubmed	Further studies on polymorphic expression of GM1 and GD1a in mouse liver. The presence of a third allele on the Ggm-1 locus.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2808323
Pubmed	Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12459592
Pubmed	A saturation hypothesis to explain both enhanced and impaired learning with enhanced plasticity.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	28234229
Pubmed	Induction of the H-2 D antigen during B cell activation.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2642506
Pubmed	A complex major histocompatibility complex D locus variant generated by an unusual recombination mechanism in mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	9037062
Pubmed	Natural killer cell tolerance persists despite significant reduction of self MHC class I on normal target cells in mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	20957233
Pubmed	Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	11580250
Pubmed	Convergent recombination shapes the clonotypic landscape of the naive T-cell repertoire.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	20974936
Pubmed	The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10704462
Pubmed	A novel H-2K splice form: predictions for other alternative H-2 splicing events.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2908875
Pubmed	Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3458188
Pubmed	Antigens expressed by myelinating glia cells induce peripheral cross-tolerance of endogenous CD8+ T cells.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19462379
Pubmed	Comparison of the cloned H-2Kbm1 variant gene with the H-2Kb gene shows a cluster of seven nucleotide differences.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6300887
Pubmed	H-2-linked regulation of xenotropic murine leukemia virus expression.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6300850
Pubmed	The assembly of H2-Kb class I molecules translated in vitro requires oxidized glutathione and peptide.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8500526
Pubmed	cDNA clone coding for part of a mouse H-2d major histocompatibility antigen.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6265910
Pubmed	DNA polymorphisms defined by the Tu108 probe map to the Tla region of mouse chromosome 17.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2906539
Pubmed	A single nucleotide difference at the 3' end of an intron causes differential splicing of two histocompatibility genes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3013627
Pubmed	Structure of a gene encoding a murine thymus leukemia antigen, and organization of Tla genes in the BALB/c mouse.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3894562
Pubmed	Evolution of the mouse H-2K region: a hot spot of mutation associated with genes transcribed in embryos and/or germ cells.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1348042
Pubmed	H2-K(b) and H2-D(b) regulate cerebellar long-term depression and limit motor learning.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19346486
Pubmed	Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	18383043
Pubmed	A physical map of the Q region of B1O.P.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8833240
Pubmed	Transplantation tolerance to a single noninherited MHC class I maternal alloantigen studied in a TCR-transgenic mouse model.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	21178009
Pubmed	Extensive deletions in the Q region of the mouse major histocompatibility complex.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3025084
Pubmed	The class I major histocompatibility antigen gene activated in a line of SV40-transformed mouse cells is H-2Dd, not Qa/Tla.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2989712
Pubmed	Unique biochemical properties of a mutant MHC class I molecule, H-2Ksm1.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1280760
Pubmed	Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6786753
Pubmed	Detection of a secreted form of the murine H-2 class I antigen with an antibody against its predicted carboxyl terminus.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6583704
Pubmed	Expression of H-2Dd and H-2Ld mouse major histocompatibility antigen genes in L cells after DNA-mediated gene transfer.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6571712
Pubmed	Probing for membrane domains in the endoplasmic reticulum: retention and degradation of unassembled MHC class I molecules.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12006653
Pubmed	Identification of an H-2 Kb-presented Moloney murine leukemia virus cytotoxic T-lymphocyte epitope that displays enhanced recognition in H-2 Db mutant bm13 mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7520098
Pubmed	Cooperative binding of the class I major histocompatibility complex cytoplasmic domain and human immunodeficiency virus type 1 Nef to the endosomal AP-1 complex via its mu subunit.	HLA-A HLA-B HLA-E HLA-G AP1M1	2.25e-10	7	225	5	18057255
Pubmed	Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10452993
Pubmed	Adopting the rapamycin trapping assay to track the trafficking of murine MHC class I alleles, H-2K(b).	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	26714929
Pubmed	Clusters of genes encoding mouse transplantation antigens.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6280871
Pubmed	Major histocompatibility complex class I gene controls the generation of gamma interferon-producing CD4(+) and CD8(+) T cells important for recovery from friend retrovirus-induced leukemia.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10799615
Pubmed	Viral escape at the molecular level explained by quantitative T-cell receptor/peptide/MHC interactions and the crystal structure of a peptide/MHC complex.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10993729
Pubmed	MHC class I Dk locus and Ly49G2+ NK cells confer H-2k resistance to murine cytomegalovirus.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19454713
Pubmed	Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+ T cell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10229092
Pubmed	Molecular studies of murine mutant BALB/c-H-2dm2 define a deletion of several class I genes including the entire H-2Ld gene.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2879284
Pubmed	Amino acid sequence of the carboxyl-terminal hydrophilic region of the H-2Kb MHC alloantigen. Completion of the entire primary structure of the H-2Kb molecule.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7306483
Pubmed	Molecular evidence that the H-2D and H-2L genes arose by duplication. Differences between the evolution of the class I genes in mice and humans.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2351932
Pubmed	Nucleotide sequence analysis of H-2Df and the spontaneous in vivo H-2Dfm2 mutation.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1731192
Pubmed	Detailed mapping of the Rfv-1 gene that influences spontaneous recovery from Friend retrovirus-induced leukaemia.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1627536
Pubmed	The Impact of MHC Class I Dose on Development and Maintenance of the Polyclonal Naive CD8+ T Cell Repertoire.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	32341060
Pubmed	H-2 class I and Gt (H-2) antigens are identical: evidence from H-2 mutant mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2422118
Pubmed	MHC class I H2-Kb negatively regulates neural progenitor cell proliferation by inhibiting FGFR signaling.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	34181639
Pubmed	Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	15809355
Pubmed	Thymus-leukemia (TL) antigens of the mouse. Analysis of TL mRNA and TL cDNA TL+ and TL- strains.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3840195
Pubmed	Mouse histocompatibility genes: structure and organisation of a Kd gene.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	11894934
Pubmed	Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis: implications for juvenile myositis.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19700752
Pubmed	The DNA sequence of the H-2kb gene: evidence for gene conversion as a mechanism for the generation of polymorphism in histocompatibilty antigens.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	11894963
Pubmed	Skewing of the NK cell repertoire by MHC class I via quantitatively controlled enrichment and contraction of specific Ly49 subsets.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	22287714
Pubmed	Molecular basis of the dm1 mutation in the major histocompatibility complex of the mouse: a D/L hybrid gene.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2997361
Pubmed	Nucleotide sequences of three H-2K and three H-2D complementary DNA clones coding mouse class I MHC heavy chain proteins.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	9869916
Pubmed	Qat-4 and Qat-5, new murine T-cell antigens governed by the Tla region and identified by monoclonal antibodies.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	312902
Pubmed	The nucleotide sequence of the H-2K gene of C3Hf/HeN mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3335396
Pubmed	Alternative RNA splicing in expression of the H-2K gene.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6689056
Pubmed	H2-M3-restricted CD8+ T cells are not required for MHC class Ib-restricted immunity against Listeria monocytogenes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	16461341
Pubmed	A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6895187
Pubmed	Genetic control of corticosteroid side-chain isomerase activity in the mouse.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6822218
Pubmed	The structure of H-2K(b) and K(bm8) complexed to a herpes simplex virus determinant: evidence for a conformational switch that governs T cell repertoire selection and viral resistance.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	15210799
Pubmed	NK gene complex and chromosome 19 loci enhance MHC resistance to murine cytomegalovirus infection.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19820922
Pubmed	Divergent effects of H-2K and H-2D genes on sensitivity of BL6 melanoma cells to NK cells or TNF-mediated cytotoxicity.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8181071
Pubmed	Generation of tissue-specific H-2Kd transgenic mice for the study of K(d)-restricted malaria epitope-specific CD8+ T-cell responses in vivo.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	23142461
Pubmed	Structure of C-terminal half of two H-2 antigens from cloned mRNA.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6895103
Pubmed	Nucleotide sequences of H2g7 K and D loci of nonobese diabetic mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7759137
Pubmed	A crucial role of the H-2 D locus in the regulation of both the D- and the K-associated cytotoxic T lymphocyte response against Moloney leukemia virus, demonstrated with two Db mutants.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6799575
Pubmed	Qa antigen expression on functional lymphoid, myeloid, and stem cells in adult mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	6966299
Pubmed	Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12140378
Pubmed	Structural analysis of TL genes of the mouse.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2410925
Pubmed	Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12421934
Pubmed	Molecular cloning and sequencing of H-2Kk cDNA: comparison with other H-2 genes and evidence for alternative splicing.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	3840763
Pubmed	Competition between MHC class I alleles for cell surface expression alters CTL responses to influenza A virus.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12421940
Pubmed	Major histocompatibility complex (MHC) class I KbDb -/- deficient mice possess functional CD8+ T cells and natural killer cells.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	9770513
Pubmed	Ethanol metabolism alters major histocompatibility complex class I-restricted antigen presentation in liver cells.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19195028
Pubmed	Structural definition of the H-2Kd peptide-binding motif.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	16473882
Pubmed	HLA-G transgenic mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	10479061
Pubmed	Structural relationships among the H-2 D-regions of murine MHC haplotypes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2909618
Pubmed	Structural analysis of H-2Kj and H-2Ku.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8168857
Pubmed	BH3 mimetics antagonizing restricted prosurvival Bcl-2 proteins represent another class of selective immune modulatory drugs.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	20534453
Pubmed	A single-chain H-2Db molecule presenting an influenza virus nucleoprotein epitope shows enhanced ability at stimulating CD8+ T cell responses in vivo.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	19342630
Pubmed	Inactivation of the H-2Klk gene could involve the substitutions of methylated CpGs.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	2212699
Pubmed	Class Ia MHC-deficient BALB/c mice generate CD8+ T cell-mediated protective immunity against Listeria monocytogenes infection.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	12817010
Pubmed	Transcription of HLA-G transgenes commences shortly after implantation during embryonic development in mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7530689
Pubmed	MHC class I polymorphism in lupus-prone MRL/Mp mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8781130
Pubmed	VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	14630790
Pubmed	Expression of major histocompatibility complex class I antigens at low levels in the thymus induces T cell tolerance via a non-deletional mechanism.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1396970
Pubmed	Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	16054612
Pubmed	Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	8022824
Pubmed	Clonally related CD8+ T cells responsible for rapid population of both diffuse nasal-associated lymphoid tissue and lung after respiratory virus infection.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	21690324
Pubmed	The complete amino acid sequence of the murine transplantation antigen H-2Db as deduced by molecular cloning.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7118211
Pubmed	Primary structure of the H-2Db alloantigen. II. Additional amino acid sequence information, localization of a third site of glycosylation and evidence for K and D region specific sequences.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	7118212
Pubmed	Structural and functional analysis of three D/L-like class I molecules from H-2v: indications of an ancestral family of D/L genes.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	1370689
Pubmed	CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent.	HLA-A HLA-B HLA-E HLA-G HLA-H	2.25e-10	7	225	5	17785832
Interaction	RAB11A interactions	HLA-A VPS13C LRRK2 ITGA6 SLC30A4 CEMIP2 LRP8 MRC2 USP32 VPS13A SLC39A6 CORO7 RAF1 ABCC1 SDK2 FN1 KIAA1549 FNDC3A NECTIN3 ARAF PPP2R1B IGF2R LRP1 TMEM102 CRYBG3 OCLN MTDH EPHA8	1.08e-07	830	219	28	int:RAB11A
Interaction	RHOB interactions	HLA-A HLA-B NOL6 ITGA6 DGKH TENM2 CEMIP2 LRP8 MRC2 USP32 VPS13A PLCB1 SLC39A6 SDK1 ABCC1 SDK2 ANK3 KIAA1549 ABCC5 NECTIN3 PIAS1 RAB18 IGF2R TRABD OCLN CDH2	1.61e-06	840	219	26	int:RHOB
Interaction	HLA-E interactions	HLA-A HLA-B HLA-E HLA-G HLA-H ITGA6 BRICD5 TCTN2	2.30e-06	79	219	8	int:HLA-E
Interaction	DEFB107A interactions	ZZEF1 SPIN1 SPIN2B SPIN3	8.98e-06	13	219	4	int:DEFB107A
Interaction	RAB4A interactions	HLA-A VPS13C SLC30A4 CEMIP2 LRP8 RBSN CANT1 MRC2 VPS13A SLC39A6 RAF1 KIAA1549 FNDC3A VPS13D IGF2R LRP1 OCLN	1.13e-05	457	219	17	int:RAB4A
Interaction	LAMP2 interactions	CLGN HLA-A VPS13C SLC30A4 LRP8 RBSN CANT1 USP32 PLCB1 SLC39A6 AP1M1 RAF1 ABCC1 KIAA1549 FNDC3A RAB18 IGF2R OCLN RUBCN EP300	1.18e-05	609	219	20	int:LAMP2
Interaction	LAMTOR1 interactions	HLA-A VPS13C TBC1D7 SLC30A4 CEMIP2 LRP8 CANT1 USP32 SLC39A6 RAF1 ABCC1 VRK1 CAPZA2 KIAA1549 ABCC5 ARAF IGF2R PEBP1 TRABD AGK CRYBG3 OCLN	1.37e-05	722	219	22	int:LAMTOR1
Interaction	LARGE2 interactions	HLA-G ADGRE4P MPPE1 TMEM25 EPDR1 TCTN2	1.46e-05	49	219	6	int:LARGE2
Interaction	LGALS8 interactions	LRRK2 ITGA6 MRC2 NECTIN1 SDK1 RAF1 ABCC1 FN1 KIAA1549 NECTIN3	2.14e-05	174	219	10	int:LGALS8
Interaction	LGALS7 interactions	INTS14 PKD1 SDK1 SDK2 FN1 KIAA1549 DPYSL4 PRPF8 VCAN	2.17e-05	139	219	9	int:LGALS7
Interaction	HLA-H interactions	HLA-B HLA-E HLA-G HLA-H	2.89e-05	17	219	4	int:HLA-H
Interaction	HYAL2 interactions	CLGN HLA-G ADGRE4P BRICD5 MPPE1 TMEM25 TCTN2	3.35e-05	83	219	7	int:HYAL2
Interaction	HLA-G interactions	HLA-A HLA-B HLA-E HLA-G HLA-H ADGRG1 MRC2 SLC39A6	4.49e-05	118	219	8	int:HLA-G
Interaction	FBXO2 interactions	ITGA6 ADGRG1 CEMIP2 MRC2 PVR RAF1 SDK2 FN1 NECTIN3 CEMIP TMEM25 IGF2R CTBS EPDR1 TCTN2	4.65e-05	411	219	15	int:FBXO2
Interaction	MR1 interactions	HLA-B HLA-E HLA-G BRICD5 MPPE1 TCTN2	4.72e-05	60	219	6	int:MR1
Interaction	RAB2A interactions	HLA-A VPS13C ITGA6 CEMIP2 LRP8 RBSN CANT1 VPS13A PLCB1 SLC39A6 CEP97 RAF1 ABCC1 KIAA1549 ABCC5 IGF2R OCLN EP300	5.08e-05	567	219	18	int:RAB2A
Interaction	ZDHHC15 interactions	ZNF112 PVR ATRNL1 LRP1 CTBS LIMCH1 CRYBG3 ZNF292	6.77e-05	125	219	8	int:ZDHHC15
Interaction	LGALS1 interactions	ITGA6 CEMIP2 FREM2 MRC2 SDK1 SDK2 FN1 NRCAM KIAA1549 NECTIN3 IGDCC4 IGF2R VCAN	7.42e-05	332	219	13	int:LGALS1
Interaction	LAMP1 interactions	HLA-A ITGA6 SLC30A4 TENM2 CEMIP2 CANT1 PVR USP32 PLCB1 SLC39A6 AP1M1 RAF1 ABCC1 ABCC5 FNDC3A IGF2R OCLN CDH2 MTDH	8.32e-05	644	219	19	int:LAMP1
Cytoband	16p13.1	ABCC1 ABCC6	1.41e-04	4	224	2	16p13.1
Cytoband	Xp11.1	SPIN2A SPIN2B	1.41e-04	4	224	2	Xp11.1
Cytoband	Ensembl 112 genes in cytogenetic band chr9q21	TRPM6 CEMIP2 SPATA31D4 SPATA31D3 CTSL3P VPS13A	4.61e-04	199	224	6	chr9q21
GeneFamily	Fibronectin type III domain containing	NFASC FNDC1 ASTN2 ROBO3 SDK1 SDK2 FN1 NRCAM KALRN FNDC4 FNDC3A IGDCC4 TNN TNXB EPHA8	7.71e-12	160	155	15	555
GeneFamily	Tudor domain containing\|Spindlin family	SPIN1 SPIN2A SPIN2B SPIN3	2.58e-08	5	155	4	1089
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	NFASC HMCN2 ROBO3 SDK1 SDK2 NRCAM KALRN NECTIN3 IGDCC4 HMCN1 ALPK2	1.42e-07	161	155	11	593
GeneFamily	Immunoglobulin like domain containing	VSIG4 HMCN2 PVR NECTIN1 ROBO3 SDK1 SDK2 NRCAM NECTIN3 IGDCC4 LY9	8.76e-07	193	155	11	594
GeneFamily	ATP binding cassette subfamily C	ABCC1 ABCC5 ABCC6 ABCC12	3.50e-06	13	155	4	807
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	BRAF RAF1 ARAF	6.10e-06	5	155	3	1157
GeneFamily	Histocompatibility complex\|C1-set domain containing	HLA-A HLA-B HLA-E HLA-G HLA-H	3.60e-05	44	155	5	588
GeneFamily	Mitogen-activated protein kinase kinase kinases\|RAF family	BRAF MAP3K19 RAF1 ARAF	4.83e-05	24	155	4	654
GeneFamily	Tudor domain containing	SPIN1 SPIN2A SPIN2B SPIN3	2.75e-04	37	155	4	780
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	PVR NECTIN1 NECTIN3 TMEM25	3.73e-04	40	155	4	592
GeneFamily	C1-set domain containing	HLA-A HLA-B HLA-E HLA-G	4.51e-04	42	155	4	591
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	ZZEF1 MIB2 EP300	4.59e-04	18	155	3	91
GeneFamily	Adenosine receptors\|V-set domain containing	VSIG4 PVR NECTIN1 VSTM5 NECTIN3 CD300LD VCAN	5.18e-04	163	155	7	590
GeneFamily	Fibulins	HMCN2 HMCN1	1.98e-03	8	155	2	556
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ITGA6 ITGAX MRC2 PVR NECTIN1 NECTIN3 IGF2R LRP1 LY9 CDH2	2.15e-03	394	155	10	471
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	PKD1 ATRNL1 VCAN	5.19e-03	41	155	3	1298
GeneFamily	Mitogen-activated protein kinases	MAPK4 MAPK9	5.35e-03	13	155	2	651
GeneFamily	Low density lipoprotein receptors	LRP8 LRP1	5.35e-03	13	155	2	634
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_3_PRECICTIVE_ICB_RESPONSE	IL15 HLA-A HLA-B VPS13C LRRK2 HLA-E HLA-G HLA-H VPS13A FN1 CEMIP SNX25 LRP1	2.71e-08	211	218	13	MM17081
Coexpression	TABULA_MURIS_SENIS_LUNG_PULMONARY_INTERSTITIAL_FIBROBLAST_AGEING	IRF2BP2 HLA-A HLA-B HLA-E HLA-G HLA-H	3.67e-08	24	218	6	MM3773
Coexpression	TABULA_MURIS_SENIS_LUNG_ENDOTHELIAL_CELL_OF_LYMPHATIC_VESSEL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.54e-07	16	218	5	MM3766
Coexpression	WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN	HLA-A HLA-B HLA-E HLA-G HLA-H	4.02e-07	19	218	5	MM797
Coexpression	MIKKELSEN_NPC_ICP_WITH_H3K27ME3	HLA-A HLA-B HLA-E HLA-G HLA-H	4.02e-07	19	218	5	MM862
Coexpression	TABULA_MURIS_SENIS_BLADDER_LEUKOCYTE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	5.32e-07	20	218	5	MM3682
Coexpression	RUAN_RESPONSE_TO_TNF_UP	HLA-A HLA-B HLA-E HLA-G HLA-H	6.94e-07	21	218	5	MM651
Coexpression	DURAND_STROMA_NS_UP	HLA-A HLA-B HLA-E HLA-G HLA-H PLCB1 VSTM5 PEBP1 SLC35B4 ATRNL1 LY9	7.44e-07	194	218	11	MM962
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_DISTAL_CONVOLUTED_TUBULE_EPITHELIAL_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H ADGRG1 NECTIN3 RAB18 MTDH	1.00e-06	124	218	9	MM3726
Coexpression	RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	HLA-A HLA-B HLA-E HLA-G HLA-H	1.76e-06	25	218	5	MM672
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A HLA-B HLA-E HLA-G HLA-H ZZEF1 ABCA7 PVR PKD1 PDIA5 KHK ABCC1 FN1 ABCC5 FRMD4A LRP1	2.29e-06	470	218	16	MM1053
Coexpression	NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN	IL15 ITGA6 ADGRG1 PVR USP32 TIMM17A KHK CNGB1 MAP3K19 SDK2 FN1 ANK3 AP1M2 DPYSL4 NECTIN3 VWA7 ABCC6 FRMD4A LRP1 LIMCH1 TNXB TCTN2 ZNF292	2.35e-06	909	218	23	M41018
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	MAN2A1 DDX42 ITGA6 ZZEF1 LARP4B GSE1 VPS13A NFYC N4BP2L2 NUP153 ABCC1 STRN3 VRK1 FNDC3A NECTIN3 WDR37 DNAJC2 CEMIP IGF2R CRYBG3 CDH2 ZNF292	3.08e-06	856	218	22	M4500
Coexpression	TABULA_MURIS_SENIS_MARROW_NAIVE_T_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H MS4A3	4.57e-06	52	218	6	MM3808
Coexpression	NABA_ECM_GLYCOPROTEINS	SVEP1 FNDC1 INTS14 HMCN2 FN1 VWA7 HMCN1 TNN TNXB PCOLCE	4.88e-06	191	218	10	MM17059
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_MESANGIAL_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	5.42e-06	31	218	5	MM3729
Coexpression	NABA_ECM_GLYCOPROTEINS	SVEP1 FNDC1 INTS14 HMCN2 FN1 VWA7 HMCN1 TNN TNXB PCOLCE	6.13e-06	196	218	10	M3008
Coexpression	TABULA_MURIS_SENIS_HEART_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-E RBM26 HLA-G HLA-H	9.64e-06	59	218	6	MM3704
Coexpression	PAL_PRMT5_TARGETS_DN	HLA-A HLA-B HLA-E HLA-G HLA-H	1.01e-05	35	218	5	MM674
Coexpression	COATES_MACROPHAGE_M1_VS_M2_DN	HLA-A HLA-B HLA-E HLA-G HLA-H CD300LD IGF2R	1.04e-05	90	218	7	MM750
Coexpression	KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN	HLA-A HLA-B IGF2R	1.11e-05	6	218	3	M7182
Coexpression	TABULA_MURIS_SENIS_LUNG_CD8_POSITIVE_ALPHA_BETA_T_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.74e-05	39	218	5	MM3758
Coexpression	TABULA_MURIS_SENIS_KIDNEY_KIDNEY_CORTEX_ARTERY_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.74e-05	39	218	5	MM3725
Coexpression	NABA_CORE_MATRISOME	SVEP1 FNDC1 INTS14 HMCN2 FN1 VWA7 HMCN1 TNN VCAN TNXB PCOLCE	1.77e-05	270	218	11	MM17057
Coexpression	NABA_CORE_MATRISOME	SVEP1 FNDC1 INTS14 HMCN2 FN1 VWA7 HMCN1 TNN VCAN TNXB PCOLCE	2.10e-05	275	218	11	M5884
Coexpression	HOWLIN_CITED1_TARGETS_1_UP	HLA-A HLA-B HLA-E HLA-G HLA-H	2.23e-05	41	218	5	MM710
Coexpression	HU_GENOTOXIC_DAMAGE_4HR	HLA-A HLA-B HLA-E HLA-G HLA-H	2.83e-05	43	218	5	MM1204
Coexpression	TABULA_MURIS_SENIS_LUNG_TYPE_II_PNEUMOCYTE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	3.17e-05	44	218	5	MM3775
Coexpression	HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	HLA-B HLA-E HLA-G HLA-H DNMT3A	3.17e-05	44	218	5	MM805
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOCARDIAL_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	3.95e-05	46	218	5	MM3712
Coexpression	GSE36826_WT_VS_IL1R_KO_SKIN_UP	ZNF274 HLA-B HLA-E HLA-G ZZEF1 ITGAX ACSM5 BTBD18 ABCC5	4.28e-05	197	218	9	M9537
Coexpression	GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP	PUS3 NOL6 ITGA6 TFIP11 CEMIP2 RBSN SVIL TECPR1 FNDC4	4.28e-05	197	218	9	M4237
Coexpression	GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP	HLA-B ZZEF1 TRANK1 PLCB1 BRWD1 RAF1 SDK2 LONP2 VPS13D	4.46e-05	198	218	9	M5591
Coexpression	GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP	HLA-A ITGAX CANT1 TECPR2 MPPE1 RAF1 CAPZA2 VWA7 FRMD4A	4.63e-05	199	218	9	M5526
Coexpression	GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN	DGKH LRP8 SLC39A6 NUP153 ABCC1 STRN3 CAD PRPF8 DNAJC2	4.63e-05	199	218	9	M6932
Coexpression	GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN	TRPM6 DGKH ASTL BRAF SDK1 DPYSL4 PKHD1L1 ATRNL1 TMEM102	4.82e-05	200	218	9	M3575
Coexpression	HALLMARK_COMPLEMENT	DGKH F8 RBSN RAF1 FN1 XPNPEP1 SCG3 LRP1 SERPINC1	4.82e-05	200	218	9	M5921
Coexpression	BAUS_TFF2_TARGETS_UP	HLA-A HLA-B HLA-E HLA-G HLA-H	5.38e-05	49	218	5	MM1287
Coexpression	TABULA_MURIS_SENIS_MARROW_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	5.94e-05	50	218	5	MM3805
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_B_CELL_AGEING	HLA-A HLA-B HLA-E RBM26 HLA-G HLA-H	6.39e-05	82	218	6	MM3777
Coexpression	TABULA_MURIS_SENIS_TRACHEA_MACROPHAGE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H PEBP1	6.39e-05	82	218	6	MM3858
Coexpression	GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP	VPS13C USP32 TNRC6A NFYC AP1M1 FNDC3A CRAT ATRNL1	7.88e-05	166	218	8	M344
Coexpression	CASTELLANO_NRAS_TARGETS_UP	HLA-A HLA-B HLA-E HLA-G HLA-H FNDC3A	9.49e-05	88	218	6	MM1087
Coexpression	TABULA_MURIS_SENIS_TONGUE_KERATINOCYTE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.03e-04	56	218	5	MM3852
Coexpression	TABULA_MURIS_SENIS_LUNG_B_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H MTDH	1.08e-04	90	218	6	MM3756
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.12e-04	57	218	5	MM3716
Coexpression	LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2	ZBTB38 DGKH SVIL VPS13A SDK1 ANK3 FOXP2 ALPK2	1.18e-04	176	218	8	M39223
Coexpression	HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	HLA-B HLA-E HLA-G HLA-H MTDH	1.22e-04	58	218	5	MM661
Coexpression	KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	MAN2A1 HLA-E TENM2 TECPR1 FN1 IGDCC4 FRMD4A HMCN1 LIMCH1 CRYBG3 DSEL	1.30e-04	337	218	11	M13206
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_INTERNEURON_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	1.32e-04	59	218	5	MM3688
Coexpression	MARTINEZ_TP53_TARGETS_DN	HLA-A HLA-B HLA-E HLA-G HLA-H ADGRG1 RIOK3 TENM2 PKD1 TNRC6A PLCB1 SLC39A6 ANK3 IGDCC4 FHDC1 PCOLCE	1.38e-04	659	218	16	MM1040
Coexpression	LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3	ZBTB38 LRRK2 HLA-E SVIL VPS13A FOXP2 PEBP1 ZNF292	1.44e-04	181	218	8	M39225
Coexpression	TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING	HLA-A HLA-B TBC1D7 HLA-E HLA-G HLA-H NFASC SLC30A4 CCDC13 TRANK1 LPCAT2 CANT1 NECTIN1 NUP153 ABCC5 ERI2 TARS3 VPS13D LRP1 CTBS	1.51e-04	954	218	20	MM3689
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	MAN2A1 TRANK1 SDK1 VWA7 IGF2R LIMCH1 CRYBG3	1.54e-04	137	218	7	M34024
Coexpression	TABULA_MURIS_SENIS_MAMMARY_GLAND_MACROPHAGE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H FN1	1.63e-04	97	218	6	MM3789
Coexpression	HOLLERN_EMT_BREAST_TUMOR_UP	VSIG4 MRC2 PVR PKD1 FN1 LRP1 PCOLCE	1.76e-04	140	218	7	M617
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	MAN2A1 HLA-E HLA-G ABCA7 PDIA5 FN1 ABCC6 LRP1 SERPINC1	1.87e-04	239	218	9	MM1274
Coexpression	HOLLERN_EMT_BREAST_TUMOR_UP	VSIG4 MRC2 PVR PKD1 FN1 LRP1 PCOLCE	2.28e-04	146	218	7	MM964
Coexpression	TABULA_MURIS_SENIS_HEART_MONOCYTE_AGEING	HLA-A HLA-B HLA-E VSIG4 HLA-G HLA-H PEBP1	2.38e-04	147	218	7	MM3707
Coexpression	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	PZP FN1 PEBP1 SERPINC1 TNXB	2.41e-04	67	218	5	M1686
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	ITGA6 TNRC6A PDIA5 TECPR1 PPP2R1B VPS13D SLC35B4 SPIN3	2.56e-04	197	218	8	M7403
Coexpression	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	ZNF274 VPS13C ITGA6 N4BP2L2 ANK3 ABCC5 RAB18 LY9	2.65e-04	198	218	8	M3325
Coexpression	GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN	ZBTB38 CPED1 BRAF TMEM220 DNMT3A SLC6A16 PIAS1 LY9	2.74e-04	199	218	8	M8606
Coexpression	GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN	ITGA6 SVIL PDIA5 UNC13B VRK1 WDR36 CHD7 EPDR1	2.83e-04	200	218	8	M4578
Coexpression	GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP	NECTIN1 SLC39A6 BRWD1 FN1 TARS3 CD300LD ATRNL1 CRYBG3	2.83e-04	200	218	8	M7335
Coexpression	GSE2585_THYMIC_DC_VS_MTEC_DN	NOL6 LARP4B OTUD3 CNGB1 STRN3 NECTIN3 IGF2R TNN	2.83e-04	200	218	8	M6283
Coexpression	GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP	ZNF112 KLHL3 DCAF17 OTUD3 STRN3 FMO5 SLC6A16 ABCC5	2.83e-04	200	218	8	M4440
Coexpression	MILI_PSEUDOPODIA_HAPTOTAXIS_DN	HLA-A HLA-B HLA-E HLA-G HLA-H ZZEF1 CANT1 MRC2 SLC39A6 PDIA5 ABCC1 NOL11 ABCC5 SLC35B4 LRP1 PCOLCE	2.86e-04	703	218	16	MM1055
Coexpression	ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	PZP FN1 PEBP1 SERPINC1 TNXB	3.17e-04	71	218	5	MM1210
Coexpression	GAURNIER_PSMD4_TARGETS	HLA-A HLA-B HLA-E HLA-G HLA-H	3.61e-04	73	218	5	M11428
Coexpression	WEI_MYCN_TARGETS_WITH_E_BOX	ZBTB38 ITGA6 LRP8 CANT1 PVR GNL2 PLCB1 SLC39A6 TIMM17A CORO7 VRK1 FNDC4 NOL11 VCAN GEMIN6 EPDR1 MTDH	3.63e-04	792	218	17	M12113
Coexpression	MURARO_PANCREAS_BETA_CELL	IRF2BP2 ZBTB38 CLGN VPS13C NFASC TMEM132B GSE1 SPIN1 PLCB1 ANKRD12 NRCAM CHD7 NECTIN3 PRPF8 CADPS PEBP1 ATRNL1 SCG3 ZNF292	3.76e-04	946	218	19	M39169
Coexpression	TABULA_MURIS_SENIS_MARROW_GRANULOCYTE_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	3.84e-04	74	218	5	MM3796
Coexpression	MATZUK_SPERMATOZOA	CLGN BBS4 LRP8 PLCB1 FNDC3A PEBP1	3.91e-04	114	218	6	M1833
Coexpression	HU_FETAL_RETINA_FIBROBLAST	HLA-A HLA-E CPED1 MRC2 SVIL FN1 FOXP2 FRMD4A HMCN1 VCAN PCOLCE	4.08e-04	385	218	11	M39264
Coexpression	TABULA_MURIS_SENIS_LUNG_NK_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	4.09e-04	75	218	5	MM3759
Coexpression	TABULA_MURIS_SENIS_KIDNEY_BRUSH_CELL_AGEING	HLA-A HLA-B HLA-E HLA-G HLA-H	4.09e-04	75	218	5	MM3718
Coexpression	KARAKAS_TGFB1_SIGNALING	IL15 FN1 CDH2	4.22e-04	18	218	3	M17300
Coexpression	MATZUK_SPERMATOZOA	CLGN BBS4 LRP8 PLCB1 FNDC3A PEBP1	4.29e-04	116	218	6	MM1236
Coexpression	BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN	HLA-E HLA-G ANK3 MTDH	4.45e-04	43	218	4	MM772
Coexpression	HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL	MYH11 TBC1D7 DGKH FREM2 SVIL VPS13A KHK ABCC1 STRN3 FOXP2 RIMS1 FHDC1 CDH2 SNTA1	4.47e-04	589	218	14	M45662
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HNBML1	ZBTB38 ITGA6 NFASC TMEM132B GSE1 ANK3 FOXP2 CADPS SCG3 EPHA8	4.50e-04	328	218	10	M39064
Coexpression	GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	HLA-A HLA-B GSE1 PIAS1 TRABD MTDH RUBCN	4.62e-04	164	218	7	M5653
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HLA-A ZZEF1 ABCA7 PVR PKD1 PDIA5 KHK ABCC1 FN1 ABCC5 FRMD4A LRP1	4.78e-04	457	218	12	M1613
Coexpression	CUI_TCF21_TARGETS_2_DN	IRF2BP2 ZBTB38 HLA-E HLA-G RIOK3 DGKH TENM2 CEMIP2 VPS13A ADGRE4P TECPR1 FOXP2 FNDC3A NECTIN3 ARAF CTBS EP300 PCOLCE	4.82e-04	888	218	18	MM1018
Coexpression	GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	IL15 ZBTB38 DGKH ITGAX PVR DNMT3A CRAT	4.96e-04	166	218	7	M6701
Coexpression	MARTINEZ_RB1_TARGETS_UP	HLA-A HLA-B HLA-E HLA-G HLA-H ADGRG1 RIOK3 MRC2 SPIN1 PLCB1 ANK3 ABCC5 ERI2 AGK CTBS PCOLCE	5.07e-04	741	218	16	MM1037
Coexpression	NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP	RIOK3 TFIP11 ITGAX LARP4B SPIN2A SLC39A6 N4BP2L2 BRWD1 RAF1 ABCC1 LONP2	5.49e-04	399	218	11	M41172
Coexpression	SCHUHMACHER_MYC_TARGETS_UP	LRP8 SLC39A6 VRK1 CAD PEBP1	5.51e-04	80	218	5	M12243
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ZBTB38 SORCS1 VPS13A TNRC6A N4BP2L2 ASTN2 SDK1 ANK3	5.51e-04	221	218	8	M39222
Coexpression	DURAND_STROMA_NS_UP	HLA-A PLCB1 VSTM5 PEBP1 SLC35B4 ATRNL1 LY9	5.52e-04	169	218	7	M2582
Coexpression	GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP	CORO7 RAF1 IGDCC4 SLC8A3 IGF2R AGK TCTN2	5.52e-04	169	218	7	M9156
Coexpression	BRUINS_UVC_RESPONSE_LATE	IL15 MYH11 TBC1D7 RIOK3 SVEP1 MS4A10 SORCS1 CCDC13 NECTIN1 PKD1 PDIA5 ROBO3 FMO5 FN1 ATG7 NECTIN3 ARAF AGK RIMS1 GEMIN6 PCOLCE	5.53e-04	1136	218	21	M2247
Coexpression	PHESSE_TARGETS_OF_APC_AND_MBD2_UP	HLA-E HLA-G SPIN1	5.83e-04	20	218	3	MM890
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	IRF2BP2 IMPA1 ZNF274 RBM26 TFIP11 CANT1 NUP153 BRWD1 RAF1 CHD7 ARAF DNAJC2 RAB18 EP300 ZNF292	6.09e-04	680	218	15	M41089
Coexpression	ZENG_GU_ICB_CONTROL_METAGENE_25_PRECICTIVE_ICB_RESPONSE	HLA-A HLA-B HLA-E HLA-G HLA-H TRIM77 ITGAX LPCAT2	6.19e-04	225	218	8	MM17079
Coexpression	CAIRO_LIVER_DEVELOPMENT_DN	MAN2A1 HLA-E ABCA7 PDIA5 FN1 ABCC6 LRP1 SERPINC1	6.19e-04	225	218	8	M6175
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK1 SDK2 WDR36 IGDCC4 FRMD4A VCAN LRP1 LIMCH1 TNXB PCOLCE	2.37e-11	199	220	13	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN HMCN1 VCAN LRP1 TNXB	2.99e-10	196	220	12	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN HMCN1 VCAN LRP1 TNXB	2.99e-10	196	220	12	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	CPED1 SVEP1 MRC2 PZP SDK2 FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	3.56e-10	199	220	12	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 SVEP1 ASTN2 SDK1 SDK2 NRCAM IGDCC4 LRP1 LIMCH1 TNXB PCOLCE	1.70e-09	180	220	11	08ae0f5d95c45feba68ad99788f7af7ff4c979af
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFASC SVEP1 SORCS1 FNDC1 MRC2 PLCB1 FN1 HMCN1 VCAN LRP1 TNXB	1.91e-09	182	220	11	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 CPED1 TMEM132B SORCS1 FNDC1 PLCB1 ANK3 ATRNL1 LRP1 RIMS1 TNXB	2.27e-09	185	220	11	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN ATRNL1 VCAN LRP1	3.18e-09	191	220	11	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN ATRNL1 VCAN LRP1	3.18e-09	191	220	11	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	LA\|World / Chamber and Cluster_Paper	SVEP1 HMCN2 MRC2 PLCB1 SDK1 FN1 FOXP2 FRMD4A VCAN LRP1 TNXB	3.54e-09	193	220	11	d4bf89437216baf489ea0239136dcedf3b6714af
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN ATRNL1 VCAN LRP1	3.95e-09	195	220	11	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN ATRNL1 VCAN LRP1	3.95e-09	195	220	11	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK2 FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	4.88e-09	199	220	11	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK1 FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	5.14e-09	200	220	11	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Lung_Parenchyma-Control-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1 OCLN	5.14e-09	200	220	11	c2bde99b3bc7a8740441c1a0c1394892b940b857
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1 OCLN	5.14e-09	200	220	11	3ff9abd5e07780a59d5571da906fa15f00a1d5c2
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1 OCLN	5.14e-09	200	220	11	9970e9bde6aa2ff3aef60dcb065ff15b7463e147
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	MYH11 CPED1 SORCS1 FNDC1 MRC2 PZP ATRNL1 VCAN LRP1 RIMS1 TNXB	5.14e-09	200	220	11	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	CPED1 SVEP1 MRC2 PZP FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	5.14e-09	200	220	11	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 SVEP1 ASTN2 SDK1 SDK2 NRCAM LRP1 LIMCH1 TNXB PCOLCE	2.36e-08	180	220	10	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	SVEP1 HMCN2 LPCAT2 MRC2 PLCB1 FN1 FOXP2 VCAN LRP1 TNXB	3.38e-08	187	220	10	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	IL15 HLA-A HLA-B HLA-G HLA-H CHRNB3 SORCS1 SDK1 IGDCC4 MS4A3	3.38e-08	187	220	10	02105c82a9ba79d2f19e002188377fc3440770c2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 FNDC1 MRC2 FN1 KALRN ATRNL1 VCAN	3.93e-08	190	220	10	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 MRC2 SDK1 SDK2 NRCAM IGDCC4 VCAN LRP1 LIMCH1 PCOLCE	4.13e-08	191	220	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC SVEP1 FNDC1 HMCN2 MRC2 FN1 CEMIP VCAN LRP1 PCOLCE	4.56e-08	193	220	10	dc8e62df6121ee99b156aca6b1b3ae555739b6f2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC SVEP1 FNDC1 HMCN2 MRC2 FN1 CEMIP VCAN LRP1 PCOLCE	4.56e-08	193	220	10	e2ee077fd381bd906e6b4329f22e7d106e422a7f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 MRC2 PZP SDK1 SDK2 NRCAM IGDCC4 LRP1 LIMCH1 PCOLCE	4.78e-08	194	220	10	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	SVEP1 SORCS1 LPCAT2 MRC2 PLCB1 FN1 FOXP2 VCAN LRP1 TNXB	4.78e-08	194	220	10	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TENM2 SVEP1 MRC2 SDK1 SDK2 FN1 KALRN FRMD4A HMCN1 VCAN	4.78e-08	194	220	10	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	SVEP1 HMCN2 LPCAT2 MRC2 PLCB1 FN1 FOXP2 VCAN LRP1 TNXB	5.02e-08	195	220	10	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRK2 FREM2 MRC2 UNC13B FMO5 ANK3 SNX25 LIMCH1 FHDC1 EPDR1	5.27e-08	196	220	10	7e5addaa844e66f8160e05858c341866a80aed23
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMEM132B TENM2 PKD1 PLCB1 NRCAM KALRN FRMD4A CADPS ATRNL1 RIMS1	5.27e-08	196	220	10	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	PND10-Mesenchymal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH11 CPED1 FNDC1 FN1 NRCAM HMCN1 VCAN LRP1 LIMCH1 PCOLCE	5.27e-08	196	220	10	ace167a40adb7022b365be3c2b1cbd4ba963739a
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LRRK2 FREM2 MRC2 UNC13B FMO5 ANK3 SNX25 LIMCH1 FHDC1 EPDR1	5.53e-08	197	220	10	bf10727fbe90b71d2ac60a11711e5f0701b3799d
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 CPED1 TENM2 PLCB1 FN1 NRCAM HMCN1 CADPS VCAN TNXB	5.53e-08	197	220	10	6d0d68d460243a0259ada93ebda40fa7b3088eeb
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	TMEM132B TENM2 PKD1 PLCB1 NRCAM KALRN FRMD4A CADPS ATRNL1 RIMS1	5.80e-08	198	220	10	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SVEP1 MRC2 SDK1 FN1 NRCAM CEMIP HMCN1 VCAN LRP1 PCOLCE	5.80e-08	198	220	10	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK1 SDK2 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.08e-08	199	220	10	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK1 SDK2 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.08e-08	199	220	10	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK1 SDK2 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.08e-08	199	220	10	38ed3bc7daa993d9edcf3e7834597ebb06dd24f8
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	6.37e-08	200	220	10	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-AT2-2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1	6.37e-08	200	220	10	35c05cae30cd6b323d2662f1396ddeab08bc75fc
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	SVEP1 CEMIP2 MRC2 PZP SDK2 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.37e-08	200	220	10	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1	6.37e-08	200	220	10	3c251ad03fbbdae91dfd9037880ba43adbb03807
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	LRRK2 FREM2 UNC13B FMO5 ANK3 AP1M2 SNX25 LIMCH1 FHDC1 EPDR1	6.37e-08	200	220	10	c905451425d1c24773bb0ca69bcf0309b277d2f1
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH11 CPED1 SORCS1 FNDC1 PLCB1 PZP ANK3 ATRNL1 LRP1 TNXB	6.37e-08	200	220	10	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK2 FN1 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.37e-08	200	220	10	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP FN1 NRCAM VCAN LRP1 LIMCH1 TNXB PCOLCE	6.37e-08	200	220	10	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SVEP1 MRC2 PZP SDK2 FN1 VCAN LRP1 LIMCH1 TNXB PCOLCE	6.37e-08	200	220	10	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B ANK3 ABCC6 TMEM132D SNX25 EPDR1 OCLN	1.02e-07	159	220	9	e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 SVEP1 CHRNB3 SORCS1 FOXP2 ATP13A5 PKHD1L1 HMCN1 ABCC12	1.08e-07	160	220	9	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 SVEP1 CHRNB3 SORCS1 FOXP2 ATP13A5 PKHD1L1 HMCN1 ABCC12	1.08e-07	160	220	9	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	CV-Severe-7\|Severe / Virus stimulation, Condition and Cluster	MAN2A1 HLA-A HLA-B HLA-E CEMIP2 OTUD3 WDR36 KALRN CHD7	2.55e-07	177	220	9	82fdd6185b368f54f03de389427cbe3071d21a99
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFASC CPED1 SORCS1 HMCN2 MRC2 PLCB1 FNDC4 DPYSL4 VCAN	2.55e-07	177	220	9	bd602db857f37869ef76d14c05ef522c509f08ee
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORCS1 FREM2 TRANK1 ADAMTS20 SDK1 NRCAM KALRN PKHD1L1 HMCN1	3.54e-07	184	220	9	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORCS1 FREM2 TRANK1 ADAMTS20 SDK1 NRCAM KALRN PKHD1L1 HMCN1	3.54e-07	184	220	9	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	MOGAT1 LRRK2 VPS13A ASTN2 NRCAM FOXP2 KIAA1549 CDH2 ALPK2	3.54e-07	184	220	9	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SORCS1 FREM2 TRANK1 ADAMTS20 SDK1 NRCAM KALRN PKHD1L1 HMCN1	3.54e-07	184	220	9	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH11 CPED1 SORCS1 FNDC1 ANK3 FOXP2 ATRNL1 RIMS1 TNXB	3.70e-07	185	220	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HLA-A HLA-B HLA-G HLA-H CHRNB3 SORCS1 SDK1 IGDCC4 MS4A3	3.70e-07	185	220	9	487fa382232564f075960899d50afa0edae5d258
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SVEP1 HMCN2 MRC2 PLCB1 FN1 FOXP2 VCAN LRP1 TNXB	3.70e-07	185	220	9	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SVEP1 CHRNB3 FNDC1 MRC2 IGDCC4 SLC8A3 HMCN1 LRP1 TNXB	3.87e-07	186	220	9	94d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-Neuroblast\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFASC CEMIP2 SORCS1 CHD6 DPYSL4 CHD7 FRMD4A SCG3 CDH2	4.05e-07	187	220	9	dfc2b95d70daf533bc0cc4ce78af9f65dd75a25b
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRF2BP2 RBM26 TENM2 GSE1 FAM151A DNMT3A SDK2 CADPS SCG3	4.24e-07	188	220	9	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	FNDC1 HMCN2 FN1 HMCN1 SCG3 VCAN LRP1 TNXB PCOLCE	4.24e-07	188	220	9	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 DGKH SVIL PLCB1 ASTN2 SDK1 FOXP2 IGDCC4 OCLN	4.43e-07	189	220	9	aadb7a2de4cbe7f0958651f2739bba430b93f5c1
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK2 DGKH SVIL PLCB1 ASTN2 SDK1 FOXP2 IGDCC4 OCLN	4.43e-07	189	220	9	8977f3295b7df7c7474b3f371de90a82ae4bb50c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 ASTN2 PZP SDK1 SDK2 NRCAM LRP1 LIMCH1 PCOLCE	4.43e-07	189	220	9	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.43e-07	189	220	9	c734e5693808a0333139e87bd5be2597a9252afe
ToppCell	COVID-19-lung-AT2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	LRRK2 UNC13B FMO5 ANK3 FOXP2 ABCC6 SNX25 LIMCH1 FHDC1	4.63e-07	190	220	9	27a1a86620fe9b5ee930d388b32352206485e6d0
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.63e-07	190	220	9	2e592323085ba9c019d678ac2a784462ab470ed9
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 MRC2 SDK1 SDK2 NRCAM IGDCC4 FRMD4A VCAN LRP1	4.63e-07	190	220	9	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.63e-07	190	220	9	445952b70abffadb6ccc1ed4bbf61a88b06b73b3
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.84e-07	191	220	9	c54c420a94dc749ebc67fc64c5614663f4b9798d
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FNDC1 MRC2 FN1 VCAN LRP1 EPDR1 TNXB ALPK2 PCOLCE	4.84e-07	191	220	9	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	4.84e-07	191	220	9	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CPED1 SVEP1 MRC2 FN1 NRCAM IGF2R VCAN LRP1 LIMCH1	4.84e-07	191	220	9	3379d145d34f89150f7b06d1340022cfc6b4a6ce
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CEMIP2 MRC2 SDK1 SDK2 FN1 NRCAM KALRN FRMD4A VCAN	4.84e-07	191	220	9	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	COVID-19-lung-AT2\|lung / Disease (COVID-19 only), tissue and cell type	LRRK2 FREM2 UNC13B ANK3 FOXP2 ABCC6 SNX25 LIMCH1 FHDC1	4.84e-07	191	220	9	276455a64c2c3503d5048615762eb2ee37f0ac70
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	NFASC CEMIP2 SORCS1 CHD6 DPYSL4 CHD7 FRMD4A SCG3 CDH2	4.84e-07	191	220	9	a53616c84178eb6c29b48662358765b082df3f97
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.84e-07	191	220	9	806b94f567ea09a9f443cd4091e70cdb1253ac08
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	NFASC CPED1 SVEP1 MRC2 PLCB1 ATRNL1 VCAN LRP1 CRYBG3	4.84e-07	191	220	9	cb0aee740b08f7d5fdd2717ecf7429043b277ae7
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 FREM2 LARP4B UNC13B ANK3 FOXP2 ABCC6 LIMCH1 OCLN	4.84e-07	191	220	9	ca5669bd6f4a17471acae3eb229f845cc2e08efa
ToppCell	Epithelial\|World / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B ANK3 FOXP2 ABCC6 SNX25 LIMCH1 OCLN	5.06e-07	192	220	9	499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B ANK3 FOXP2 ABCC6 SNX25 LIMCH1 OCLN	5.06e-07	192	220	9	29f49f00770c991b5f27e4cb701dd2d2d6cb7178
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D122\|Adult / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	5.06e-07	192	220	9	06013a07e3a873b1d1c0451643c528593ac32a9c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 SVEP1 MRC2 PZP SDK1 FN1 NRCAM LRP1 PCOLCE	5.06e-07	192	220	9	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 NFASC CPED1 SVEP1 MRC2 ATRNL1 VCAN LRP1 TNXB	5.06e-07	192	220	9	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	PND14-Mesenchymal-Mesenchymal_structural\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 SVEP1 MRC2 FN1 NRCAM VCAN LRP1 LIMCH1 PCOLCE	5.06e-07	192	220	9	25492568f9cbe097b7bb1db50d8b817c80ea87d7
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 MRC2 SDK1 SDK2 NRCAM IGDCC4 LRP1 LIMCH1 PCOLCE	5.06e-07	192	220	9	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	Epithelial-alveolar_epithelial_cell_type_2\|World / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	5.06e-07	192	220	9	58c3737be7acce39fd2b91d70d6d7b2bbaa4f710
ToppCell	PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPED1 SVEP1 MRC2 FN1 NRCAM VCAN LRP1 LIMCH1 PCOLCE	5.06e-07	192	220	9	de9c1536d5aee86f9c62acbc54ca8fa581c00f17
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 SVEP1 MRC2 PZP SDK1 SDK2 NRCAM LRP1 PCOLCE	5.06e-07	192	220	9	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SVEP1 MRC2 SDK1 SDK2 NRCAM IGDCC4 LRP1 LIMCH1 PCOLCE	5.06e-07	192	220	9	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	5.28e-07	193	220	9	f3cc7cfdbc164a4ed42f87647111522b7d393bcb
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	5.28e-07	193	220	9	fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPED1 SVEP1 MRC2 ASTN2 SDK1 NRCAM LRP1 LIMCH1 PCOLCE	5.28e-07	193	220	9	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	MYH11 SVIL ASTN2 B3GLCT ANK3 CADPS MAPK4 CDH2 ALPK2	5.51e-07	194	220	9	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	LRRK2 FREM2 UNC13B FMO5 ANK3 FOXP2 SNX25 LIMCH1 FHDC1	5.51e-07	194	220	9	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	TENM2 SVIL ASTN2 B3GLCT ANK3 CADPS MAPK4 CDH2 ALPK2	5.51e-07	194	220	9	c3535f7cc0076653c72db582047cff053c322397
Computational	Genes in the cancer module 293.	HLA-A HLA-B HLA-E HLA-G	1.06e-05	12	134	4	MODULE_293
Computational	Genes in the cancer module 143.	HLA-A HLA-B HLA-E HLA-G	2.10e-05	14	134	4	MODULE_143
Computational	Neighborhood of HLA-C	HLA-A HLA-B HLA-E HLA-G CORO7	2.82e-04	47	134	5	GNF2_HLA_C
Computational	Neighborhood of PTPN6	HLA-A HLA-B HLA-E HLA-G CORO7	2.82e-04	47	134	5	GNF2_PTPN6
Drug	AC1L9IGO	IL15 HLA-A ITGAX BRAF PVR RAF1 FN1 FNDC3A MAPK4 MAPK9 EP300	1.71e-06	184	218	11	CID000445722
Drug	AC1L2ZKY	RAF1 FN1 PEBP1	3.44e-06	4	218	3	CID000131675
Drug	grepafloxacin glucuronide	ABCC1 ABCC5 ABCC6	3.44e-06	4	218	3	CID000443296
Disease	graft-versus-host disease (implicated_via_orthology)	HLA-A HLA-B HLA-E HLA-G	8.75e-08	7	211	4	DOID:0081267 (implicated_via_orthology)
Disease	mean platelet volume	MYH11 ZBTB38 HLA-B LRRK2 ITGA6 NFASC SVEP1 TRANK1 GSE1 SVIL PVR TNRC6A PLCB1 PDIA5 N4BP2L2 STRN3 KALRN CAPZA2 ABCC5 CHD7 VWA7 TRABD SLC35B4 SPIN3	3.50e-07	1020	211	24	EFO_0004584
Disease	autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology)	VPS13C VPS13A VPS13D	3.61e-07	3	211	3	DOID:0111611 (implicated_via_orthology)
Disease	platelet component distribution width	HLA-B LRRK2 ZZEF1 SVEP1 TRANK1 GSE1 SVIL PVR PLCB1 PDIA5 N4BP2L2 BRWD1 KALRN CAPZA2 ABCC5 VWA7 SLC35B4 TNN TNXB SPIN3	5.78e-07	755	211	20	EFO_0007984
Disease	Colorectal Carcinoma	GSE1 BRAF VPS13A PZP UNC13B ABCC1 CAD FN1 NRCAM KALRN ABCC5 ERI2 ABCC6 PPP2R1B LRP1 DSEL MTDH EP300 ZNF292	8.16e-07	702	211	19	C0009402
Disease	Malignant neoplasm of breast	ADAT3 SORCS1 BRAF NFYC PLCB1 SLC39A6 AP1M1 ASTN2 DNMT3A RAF1 ABCC1 FN1 NRCAM KALRN ARAF TMEM25 SLC8A3 NLRP14 OCLN CDH2 MTDH EP300	1.02e-05	1074	211	22	C0006142
Disease	Pilomyxoid astrocytoma	BRAF RAF1 KIAA1549	1.24e-05	7	211	3	C1519086
Disease	Disorder of eye	BBS4 GPR179 FREM2 CNGB1 B3GLCT PRPF8 VCAN RIMS1 TCTN2	2.37e-05	212	211	9	C0015397
Disease	Parapsoriasis en Plaques	HLA-A HLA-E	5.09e-05	2	211	2	C0162442
Disease	–	HLA-A HLA-B	5.09e-05	2	211	2	608579
Disease	Erythroderma, Maculopapular	HLA-A HLA-E	5.09e-05	2	211	2	C0014799
Disease	Parakeratosis Variegata	HLA-A HLA-E	5.09e-05	2	211	2	C0030437
Disease	Parapsoriasis	HLA-A HLA-E	5.09e-05	2	211	2	C0030491
Disease	triacylglycerol 50:0 measurement	PLCB1 IGF2R	5.09e-05	2	211	2	EFO_0021480
Disease	transmembrane protein 132B measurement	TMEM132B TMEM132D	5.09e-05	2	211	2	EFO_0802151
Disease	Susceptibility to severe cutaneous adverse reaction	HLA-A HLA-B	5.09e-05	2	211	2	cv:C1840548
Disease	Carbamazepine response	HLA-A HLA-B	5.09e-05	2	211	2	cv:CN077964
Disease	Parkinson's disease 23 (implicated_via_orthology)	VPS13C VPS13A	5.09e-05	2	211	2	DOID:0060896 (implicated_via_orthology)
Disease	choreaacanthocytosis (implicated_via_orthology)	VPS13C VPS13A	5.09e-05	2	211	2	DOID:0050766 (implicated_via_orthology)
Disease	platelet measurement	HLA-B LRRK2 SVEP1 GSE1 TECPR2 PDIA5 KALRN CAPZA2 SLC8A3 SLC35B4	9.80e-05	315	211	10	EFO_0005036
Disease	Breast Carcinoma	BRAF SLC39A6 DNMT3A RAF1 ABCC1 FN1 NRCAM ARAF TMEM25 OCLN CDH2 MTDH EP300	1.46e-04	538	211	13	C0678222
Disease	Cohen syndrome (implicated_via_orthology)	VPS13C VPS13A	1.52e-04	3	211	2	DOID:0111590 (implicated_via_orthology)
Disease	Noonan syndrome with multiple lentigines	BRAF RAF1	1.52e-04	3	211	2	cv:C0175704
Disease	immature platelet measurement	HLA-B GSE1 SVIL PDIA5 KALRN CAPZA2	2.21e-04	119	211	6	EFO_0803541
Disease	systemic lupus erythematosus (implicated_via_orthology)	MAN2A1 ATG7 RUBCN EP300	2.52e-04	43	211	4	DOID:9074 (implicated_via_orthology)
Disease	high grade glioma (implicated_via_orthology)	BRAF RAF1 ATG7 ARAF	2.76e-04	44	211	4	DOID:3070 (implicated_via_orthology)
Disease	CD166 antigen measurement	ABCC1 ABCC6	3.02e-04	4	211	2	EFO_0020245
Disease	occupational asthma (is_implicated_in)	HLA-B HLA-E	3.02e-04	4	211	2	DOID:0080820 (is_implicated_in)
Disease	Stevens-Johnson syndrome (is_implicated_in)	HLA-A HLA-B	3.02e-04	4	211	2	DOID:0050426 (is_implicated_in)
Disease	Mammary Carcinoma, Human	SLC39A6 DNMT3A RAF1 ABCC1 FN1 NRCAM ARAF TMEM25 OCLN CDH2 MTDH EP300	4.31e-04	525	211	12	C4704874
Disease	Mammary Neoplasms, Human	SLC39A6 DNMT3A RAF1 ABCC1 FN1 NRCAM ARAF TMEM25 OCLN CDH2 MTDH EP300	4.31e-04	525	211	12	C1257931
Disease	Mammary Neoplasms	SLC39A6 DNMT3A RAF1 ABCC1 FN1 NRCAM ARAF TMEM25 OCLN CDH2 MTDH EP300	4.45e-04	527	211	12	C1458155
Disease	age at first sexual intercourse measurement	IRF2BP2 NFASC TENM2 CHRNB3 TNRC6A SDK1 BRWD1 FOXP2 AP1M2 ZNF292	4.67e-04	383	211	10	EFO_0009749
Disease	lactosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement	ABCA7 CHD7	5.02e-04	5	211	2	EFO_0800429
Disease	platelet crit	HLA-A HLA-B LRRK2 HLA-E ITGAX GSE1 SVIL PLCB1 PDIA5 KALRN CAPZA2 AP1M2 ABCC5 PIAS1 TRABD SLC35B4 SPIN3	5.27e-04	952	211	17	EFO_0007985
Disease	health study participation	IRF2BP2 TENM2 TNRC6A AP1M1 B3GLCT FOXP2 VWA7	5.32e-04	195	211	7	EFO_0010130
Disease	Autistic Disorder	IL15 HLA-A ASTN2 ROBO3 NRCAM FOXP2 RIMS1 ZNF292	6.14e-04	261	211	8	C0004352
Disease	Bipolar Disorder	IMPA1 HLA-E HLA-G DGKH CHRNB3 TRANK1 PLCB1 ASTN2 MPPE1 ANK3 RIMS1	6.91e-04	477	211	11	C0005586
Disease	Takayasu arteritis	HLA-A HLA-B SVEP1 TRANK1 VWA7 FRMD4A	7.07e-04	148	211	6	EFO_1001857
Disease	dietary heme iron intake measurement, type 2 diabetes mellitus	SVEP1 TNRC6A	7.49e-04	6	211	2	EFO_0008355, MONDO_0005148
Disease	Leopard Syndrome 1	BRAF RAF1	7.49e-04	6	211	2	C4551484
Disease	Colorectal Neoplasms	BRAF ABCC1 NRCAM ABCC5 ABCC6 MTDH EP300 ZNF292	9.02e-04	277	211	8	C0009404
Disease	immature platelet count	HLA-B PVR PDIA5 KALRN CAPZA2	1.01e-03	106	211	5	EFO_0803544
Disease	Common Migraine	ASTN2 LRP1	1.04e-03	7	211	2	C0338480
Disease	CHARGE syndrome (implicated_via_orthology)	CHD6 CHD7	1.04e-03	7	211	2	DOID:0050834 (implicated_via_orthology)
Disease	Abnormality of the eye	WDR37 CDH2	1.04e-03	7	211	2	C4316870
Disease	Polyomavirus Infections	IL15 GPR179	1.04e-03	7	211	2	C0949804
Disease	MASA syndrome (implicated_via_orthology)	NFASC NRCAM	1.04e-03	7	211	2	DOID:0060246 (implicated_via_orthology)
Disease	Drug-Induced Stevens Johnson Syndrome	HLA-A HLA-B EP300	1.15e-03	29	211	3	C1274933
Disease	Mycoplasma-Induced Stevens-Johnson Syndrome	HLA-A HLA-B EP300	1.15e-03	29	211	3	C3658301
Disease	Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum	HLA-A HLA-B EP300	1.15e-03	29	211	3	C3658302
Disease	Toxic Epidermal Necrolysis	HLA-A HLA-B EP300	1.15e-03	29	211	3	C0014518
Disease	epilepsy (implicated_via_orthology)	ITGA6 NFASC UNC13B NRCAM KALRN LRP1	1.17e-03	163	211	6	DOID:1826 (implicated_via_orthology)
Disease	periodontitis	NFASC TENM2 CDKL1 CCDC13 WDR36 IGF2R CDH2	1.17e-03	223	211	7	EFO_0000649
Disease	susceptibility to cold sores measurement	HLA-B HLA-E HLA-H TNXB	1.22e-03	65	211	4	EFO_0008402
Disease	Stevens-Johnson Syndrome	HLA-A HLA-B EP300	1.27e-03	30	211	3	C0038325
Disease	waist-hip ratio	MYH11 BBS4 RIOK3 ZZEF1 CPED1 GSE1 PKD1 TNRC6A ADAMTS20 ASTN2 CORO7 DNMT3A FN1 ANK3 ATG7 CEMIP PPP2R1B CADPS RIMS1	1.36e-03	1226	211	19	EFO_0004343
Disease	Grand Mal Status Epilepticus	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0311335
Disease	Status Epilepticus, Subclinical	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0751522
Disease	Simple Partial Status Epilepticus	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0751524
Disease	Non-Convulsive Status Epilepticus	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0751523
Disease	Petit mal status	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0270823
Disease	Complex Partial Status Epilepticus	ANK3 SLC8A3 CDH2 SNTA1	1.37e-03	67	211	4	C0393734
Disease	Abnormality of the skeletal system	WDR37 ZNF292	1.39e-03	8	211	2	C4021790
Disease	response to statin, low density lipoprotein cholesterol measurement	CEMIP LIMCH1	1.39e-03	8	211	2	EFO_0004611, GO_0036273
Disease	cerebellar ataxia (implicated_via_orthology)	VPS13C VPS13A	1.39e-03	8	211	2	DOID:0050753 (implicated_via_orthology)
Disease	pantothenate measurement	TENM2 CAD	1.39e-03	8	211	2	EFO_0021034
Disease	biological sex	NFASC TENM2 SDK1 STRN3 ANK3 DPYSL4 CADPS	1.39e-03	230	211	7	PATO_0000047
Disease	Status Epilepticus	ANK3 SLC8A3 CDH2 SNTA1	1.45e-03	68	211	4	C0038220
Disease	Leukemia, Myelocytic, Acute	MYH11 VSIG4 SVIL PVR DNMT3A EP300	1.58e-03	173	211	6	C0023467
Disease	Malignant Glioma	HLA-A HLA-B BRAF RAF1	1.61e-03	70	211	4	C0555198
Disease	mixed gliomas	HLA-A HLA-B BRAF RAF1	1.61e-03	70	211	4	C0259783
Disease	cardiomyopathy (implicated_via_orthology)	BRAF RAF1 ARAF LRP1	1.70e-03	71	211	4	DOID:0050700 (implicated_via_orthology)
Disease	lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement	ABCA7 CHD7	1.77e-03	9	211	2	EFO_0800517
Disease	Noonan syndrome	BRAF RAF1	1.77e-03	9	211	2	cv:C0028326
Disease	cervical carcinoma	HLA-B HLA-E HLA-G VWA7 LY9 TNXB	2.04e-03	182	211	6	EFO_0001061
Disease	Acute Myeloid Leukemia, M1	MYH11 VSIG4 SVIL PVR DNMT3A	2.09e-03	125	211	5	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	MYH11 VSIG4 SVIL PVR DNMT3A	2.09e-03	125	211	5	C1879321
Disease	Abnormality of nervous system morphology	WDR37 ZNF292	2.21e-03	10	211	2	C4022810
Disease	cocaine use	CHRNB3 DNMT3A	2.68e-03	11	211	2	C3496069
Disease	Noonan Syndrome 1	BRAF RAF1	2.68e-03	11	211	2	C4551602
Disease	beta-2 microglobulin measurement	HLA-A HLA-B	2.68e-03	11	211	2	EFO_0005197
Disease	Turner Syndrome, Male	BRAF RAF1	2.68e-03	11	211	2	C0041409
Disease	Female Pseudo-Turner Syndrome	BRAF RAF1	2.68e-03	11	211	2	C1527404
Disease	Alzheimer disease	TENM2 ABCA7 TNRC6A ADAMTS20 POLN SDK1 ANK3 FRMD4A MS4A3 TNXB	2.72e-03	485	211	10	MONDO_0004975
Disease	cortical thickness	IRF2BP2 HLA-B CPED1 TENM2 LRP8 PKD1 TNRC6A ADAMTS20 ASTN2 STRN3 FOXP2 DPYSL4 CHD7 VPS13D CADPS VCAN LRP1	2.80e-03	1113	211	17	EFO_0004840
Disease	neuropsychological test	CDKL1 PLCB1 CAPZA2 PIAS1 RIMS1 DSEL	3.03e-03	197	211	6	EFO_0003926
Disease	intracranial aneurysm (is_implicated_in)	PKD1 VCAN	3.20e-03	12	211	2	DOID:10941 (is_implicated_in)
Disease	Vertigo	SVIL SDK2 CADPS LIMCH1 RIMS1	3.31e-03	139	211	5	HP_0002321
Disease	sporadic amyotrophic lateral sclerosis	NFASC TMEM132B GSE1 ANK3 ABCC12	3.41e-03	140	211	5	EFO_0001357
Disease	susceptibility to Mycobacterium tuberculosis infection measurement	HLA-A HLA-B HLA-E SDK1	3.42e-03	86	211	4	EFO_0008407
Disease	Glioma	HLA-A HLA-B BRAF RAF1	3.56e-03	87	211	4	C0017638
Disease	risk-taking behaviour	NFASC TMEM132B TENM2 LRP8 TNRC6A KHK SDK1 B3GLCT FOXP2 CADPS ATRNL1 TNXB EP300	3.57e-03	764	211	13	EFO_0008579
Disease	diet measurement	ZBTB38 HLA-B RBM26 RIOK3 TENM2 CHRNB3 TRANK1 TNRC6A CHD6 CNGB1 SDK1 DNMT3A ANK3 FOXP2 CADPS RIMS1	3.76e-03	1049	211	16	EFO_0008111
Disease	Adenocarcinoma of lung (disorder)	TRPM6 BRAF RAF1 ARAF EP300 EPHA8	3.77e-03	206	211	6	C0152013
Disease	Neurodegeneration with brain iron accumulation	DCAF17 CRAT	3.77e-03	13	211	2	cv:C2931845
Disease	phosphocreatine measurement	TENM2 ADAMTS20	3.77e-03	13	211	2	EFO_0010521
Disease	cholesteryl ester 20:5 measurement	SVIL CADPS CDH2	3.85e-03	44	211	3	EFO_0010349
Disease	body weight	ZBTB38 MOGAT1 HLA-B VPS13C DGKH ZZEF1 GSE1 PKD1 TNRC6A ASTN2 POLN UNC13B NRCAM FOXP2 DPYSL4 ATP13A5 CHD7 CADPS	4.31e-03	1261	211	18	EFO_0004338
Disease	migraine disorder	LARP4B TCERG1 MRC2 SVIL ASTN2 FRMD4A LRP1 LIMCH1	4.34e-03	357	211	8	MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
GTEWAQNTIVPKVLV	PPP2R1B	486	P30154
WQALPVLSEKQSGDV	ADAT3	26	Q96EY9
ILTSTVNLQEPWKSG	ERI2	576	A8K979
QPSTTGIRKQWHEDI	EP300	561	Q09472
GPQEQITVQEWSDRK	EPDR1	141	Q9UM22
SWDTPQEVIAVKSAQ	DCAF17	156	Q5H9S7
TKVIVKSNGTVVWTP	CHRNB3	131	Q05901
TKPQLAIVTQWCEGS	BRAF	521	P15056
AALQVGEALVWTKPV	BBS4	426	Q96RK4
QEVSPEVWKDVQLST	AGK	296	Q53H12
ASVTWQLVENQETGP	ATP13A5	756	Q4VNC0
ANLNPVTWVKTIGST	ERVK-9	621	Q9UKH3
PTVTNAVSWRSEGIK	AP1M2	151	Q9Y6Q5
QVTINPGTQTAVSEW	CD300LD	121	Q6UXZ3
GDRIPIVKQTWESQA	B3GLCT	281	Q6Y288
ITEGTTQEEFPWKEQ	VCAN	1026	P13611
VIVNQPLEGEETQKW	CRYBG3	2951	Q68DQ2
DVRSVTQKHIQEWGP	DNMT3A	686	Q9Y6K1
KPGDWSREQLNETTV	CPED1	241	A4D0V7
LVDTSKVQEAWVPSQ	BRICD5	141	Q6PL45
EAKTAIWQVLQPSEG	ALPK2	1486	Q86TB3
VTPVKDQCNWGSVRT	CTSL3P	71	Q5NE16
IAPTKTVNGVWRSES	GSE1	126	Q14687
TTQSNVDIWVSGVKP	ADGRE4P	111	Q86SQ3
KTTVGSVKWVPENSE	AP1M1	326	Q9BXS5
TWGLQATNAVSPLKE	COQ6	446	Q9Y2Z9
VPQKIVATWEAISLG	ACSM5	31	Q6NUN0
IWNSSLQTNKEPVGI	CRAT	236	P43155
EPSSQVGVIQNKSWE	ANKRD12	1406	Q6UB98
WVSNKTEGRITDVIP	SERPINC1	221	P01008
IEGSQVTFDVAWSPK	CTBS	171	Q01459
LEDNVQSWKPGDTLV	CEMIP	426	Q8WUJ3
VAPDWTDIVKQSGFV	CHD7	2681	Q9P2D1
FTPWTTEEQKLLEQA	DNAJC2	551	Q99543
VAQEQSWLAGVSTKP	ASTL	381	Q6HA08
EWVDVQPAIGTKVSD	ASTN2	1086	O75129
VNKETETRPVNGEWG	ADAMTS20	546	P59510
EVAKVLASGNWTPES	ABCA7	1326	Q8IZY2
TLTSQWKDVPVEQVT	POLN	656	Q7Z5Q5
SWVRQDGKPISTDVI	IGDCC4	276	Q8TDY8
TVKSRWSGSQQVEQP	RAF1	491	P04049
VEKIIQTPGLWESEN	RAB18	166	Q9NP72
AWNKPVTNISAVETE	RBM26	956	Q5T8P6
GNERQTLSWTVTPKT	PZP	856	P20742
KECIWTITVPEGQTV	PCOLCE	61	Q15113
AIEKSVVPWVNDQDV	RBSN	146	Q9H1K0
NSWVVVGAPQKITAA	ITGAX	46	P20702
EWVKNVSAGTQDVPS	OCLN	296	Q16625
QKWAAVVVPSGEEQR	HLA-H	266	P01893
SPESQSNNLWVIVGV	KIAA1549	1291	Q9HCM3
SWSVKQGQIITCPAV	NOL11	56	Q9H8H0
QKWAAVVVPSGEEQR	HLA-G	266	P17693
LQTDQAEASKPTWGT	CADPS	431	Q9ULU8
PEEQVRGKTNIWTLA	FHDC1	106	Q9C0D6
TDNPEGSWIRTVQNK	MOGAT1	236	Q96PD6
IDQWNKVIEQLGTPS	MAPK9	231	P45984
TFQKWAAVVVPSGEE	HLA-E	261	P13747
VASGTVARVEPNIKW	GNL2	66	Q13823
TAALAVQVVGSNWPK	LONP2	81	Q86WA8
KPVEVQVSAVWDTAN	MAN2A1	681	Q16706
TDQLDKSVQLSWTPG	NRCAM	656	Q92823
QIQKQEAVGPWESVD	GPR179	1641	Q6PRD1
AGLPKTEANWVNVIS	IL15	41	P40933
LEIAQWVKSTQGGPE	MAPK4	491	P31152
SFTNETVWIKPEDQL	MTO1	266	Q9Y2Z2
WTVNDRPVTEGVSEQ	HMCN2	4156	Q8NDA2
LVNVSISWPNGISVD	LRP1	2046	Q07954
SVIVDTKITWPNGLT	LRP1	3181	Q07954
KAASQQGTPWETLVV	KIAA1109	4391	Q2LD37
QGVTIWVTILPVDSQ	FREM2	1051	Q5SZK8
TKVSELNPNAEVWGA	LARP4B	51	Q92615
KEWTTTTGDVVNENP	CANT1	231	Q8WVQ1
TTGDVVNENPEWVKV	CANT1	236	Q8WVQ1
AGTTVKVWDAAKQQP	CORO7	146	P57737
VTQIVEILHSGPSKW	DDX42	471	Q86XP3
WPEVKTTASDGEQTT	MPPE1	51	Q53F39
SKWSGPLSLQEVDEQ	PEBP1	6	P30086
VWGATTQKTTEDPEA	FAM205C	306	A6NFA0
LSPAEIQQLWKEVTG	FOXP2	261	O15409
TITWKGPDQNILDTD	KALRN	2501	O60229
KQVAPDTWIVTDGAA	MS4A10	246	Q96PG2
KNSVWTQDGPSAQIL	NOL6	956	Q9H6R4
SATVGIDVKDWPIQI	LRRK2	1366	Q5S007
HLPVEKESWIVSGTQ	LRRK2	2206	Q5S007
VQGQEPQSRVKWSEA	MRC2	986	Q9UBG0
AINEGQNKPEIEVTW	F8	1631	P00451
GTATLNIQWPKEISN	ITGA6	886	P23229
QKTSSQPVQKWGTEE	DGKH	1141	Q86XP1
QKWAAVVVPSGEEQR	HLA-B	266	P01889
GPWSSEKAETNILEI	NBPF1	6	Q3BBV0
ALQWVVVEVSGTPNQ	NFYC	381	Q13952
SPFITWQKEGINVNT	HMCN1	4016	Q96RW7
NAPLWQIRGTEKSSV	OTUD3	156	Q5T2D3
DESPQGKVLQVIVWG	RIMS1	1611	Q86UR5
EIIKRTTSGGEWPQI	LPCAT2	201	Q7L5N7
VQLEEKGQGSVPWSV	ABCC5	831	O15440
DEQSIWNVTVLPNSK	NFASC	1116	O94856
GTCWEVVQETPLKNT	BTBD18	366	B2RXH4
ETTGIQTTVVFWPAK	CPLANE2	86	Q9BU20
ILTWQTGEATENSPI	FRMD4A	1011	Q9P2Q2
VAVGSDADLVIWNPK	DPYSL4	401	O14531
ATVKTRWSGAQPLEQ	ARAF	451	P10398
EIWESIKSGTALENP	ATG7	111	O95352
ANLNPVTWVKTIGST	ERVK-24	511	P61566
ANLNPVTWVKTIGST	ERVK-7	511	P61567
PSLSQEEVSIIWGNV	CCDC81	21	Q6ZN84
QRGVPEHLVKSITWQ	CDKL1	96	Q00532
WELITPTKDGQAQTL	CHD6	1156	Q8TD26
NVEWLVPDVQGSGKT	FAM151A	341	Q8WW52
VTDVQDNSISVKWLP	FN1	1641	P02751
VDSIKIAWESPQGQV	FN1	1736	P02751
ESEPVIQVNSWVGIN	CEP97	341	Q8IW35
QVNWEVPLSNGTDVT	FNDC3A	776	Q9Y2H6
VNGKPTVVAASWDAL	FNDC1	371	Q4ZHG4
NSATVSWDVPEGNIV	FNDC4	61	Q9H6D8
KQPDFATSGQWEVVT	FMO5	116	P49326
AGQTSVSLLWQEPEQ	EPHA8	451	P29322
QNVTVWIKPSGLQTD	INTS14	401	Q96SY0
RSPWGQITDLKTSEQ	CCDC191	66	Q8NCU4
SPEQKGWQAQVSEIK	CCDC13	536	Q8IYE1
DRINATVWKLQPTAG	ADGRG1	231	Q9Y653
QWEDITGTTPLTFIK	ANK3	1256	Q12955
SNTWLVPETKGAIVQ	ATRNL1	451	Q5VV63
LDDVSSWKPGDQIVV	CEMIP2	421	Q9UHN6
SNLKETISGPENVWI	BRWD1	2246	Q9NSI6
ANLNPVTWVKTIGST	ERVK-21	621	P61565
QKWAAVVVPSGEEQR	HLA-A	266	P04439
WTPLQKEAVVSQGES	LY9	396	Q9HBG7
VVDLAPSKGTVNLTW	IGHE	241	P01854
LSWDTKSEPRQEVGV	MARCHF10	401	Q8NA82
QISAGEEKWNSVSPA	MTDH	296	Q86UE4
VDVSQVAWQSKGDTP	KHK	81	P50053
SVEVYDPGTNTWKQV	KLHL3	506	Q9UH77
KGWVLTTDPVSANIV	GEMIN6	31	Q8WXD5
VEGLVSTNSPNVWSK	RUBCN	36	Q92622
TWTSVPEQDQNGLIL	SDK1	1296	Q7Z5N4
ILDTSLKVSWQEPGE	SDK2	906	Q58EX2
EGEISPTNTNVWKQN	DSEL	1171	Q8IZU8
KINGEAQPWLSTSTE	IRF2BP2	371	Q7Z5L9
ANWLKIDPVNGQITT	CDH2	541	P19022
QDWQPRTEGVEITVT	MAP3K19	71	Q56UN5
QTLVSDNIEWPNGIT	LRP8	576	Q14114
EPAFSEAQKWIEQVT	LIMCH1	21	Q9UPQ0
GSTAEDIVEWLKNPQ	PDIA5	246	Q14554
VLWASSKVVAPGQLV	PKD1	1891	P98161
STPDRTVVVQWDQGT	MIB2	46	Q96AX9
LWSLNKEDTSEQVVP	ABCC1	241	P33527
SVVAGIKPTRTWIQN	MS4A3	106	Q96HJ5
TVRKPWTAVDTSVDG	IGF2R	1101	P11717
WILVPSSQVDGKNVT	PVR	206	P15151
VADGQTVQGEVWKTT	TARS3	166	A2RTX5
PTAEVWDVDQGLISK	STRN3	336	Q13033
TEWGNVKPSVIKQTS	PUS3	386	Q9BZE2
VISDSVPGSQTWEDK	SLC6A16	21	Q9GZN6
TEVWNNLGTTKSEPQ	SLC35B4	311	Q969S0
SQDIKQIGWLTEQLP	SNTA1	291	Q13424
LKSQAWQPLVEGSEN	SVIL	926	O95425
VLQSPQQEAIVSSWI	TMEM132B	691	Q14DG7
SVQANLESKWPIVVA	TMEM132B	736	Q14DG7
SDTELNQIKGWRVPI	TMEM132D	531	Q14C87
SVAVALWKIQQGTPE	ABCC6	86	O95255
LQEVGGVETKNWTVP	SNX25	536	Q9H3E2
GEKSILTDNPTWIID	IMPA1	76	P29218
LDIIQQGQTDWPAVK	TENM2	886	Q9NT68
LQKVQESVWGLPSVV	SPATA31D4	626	Q6ZUB0
ESVWGLPSVVQKSQE	SPATA31D4	631	Q6ZUB0
GDEPITQWKGTVLDQ	SPIN2A	61	Q99865
TVPNTIVVSWTAEIG	PIAS1	261	O75925
PESSLQRVWDKVVSG	TBC1D7	216	Q9P0N9
VTWQIPTAKDNSGEK	SVEP1	586	Q4LDE5
LIQTESPQEGTVTWK	ABCC12	766	Q96J65
TGADVSIIALNQWPK	ERVK-9	806	P63128
QTTEKISPNWESGIN	SLC39A6	31	Q13433
EWKFTITPSTTQVVG	CAPZA2	176	P47755
AQIEDSSVVKPAGWL	CLGN	301	O14967
PQEKQVTITETLWDQ	C12orf54	31	Q6X4T0
RPQSTSDQKLWEEVG	CNGB1	396	Q14028
VWVPSEKQGFEAASI	MYH11	36	P35749
AGKVWLIDVSQSVEP	RIOK3	416	O14730
PQSDLRWSKQTDVGI	PRPF8	1336	Q6P2Q9
ADNPSWDGEKTIIIT	PRPF8	2201	Q6P2Q9
LQKVQESVWGLPSVV	SPATA31D3	626	P0C874
ESVWGLPSVVQKSQE	SPATA31D3	631	P0C874
VNPQLSAWTITGVSE	TRIM77	266	I1YAP6
QKIVEWKPGTQANIS	VSTM5	76	A8MXK1
GLKDTPTQEDWLVSV	XPNPEP1	96	Q9NQW7
VETSVQTWTAKEEVP	VPS13A	1531	Q96RL7
QTWTAKEEVPTQESV	VPS13A	1536	Q96RL7
VSTWSEDDILKPGQV	TRPM6	1786	Q9BX84
ETLVLSNKEVVQPGW	RNASE10	66	Q5GAN6
PEVTGNVIWKSISAI	TMEM220	51	Q6QAJ8
AQTEIDGPKNLVTDW	TNN	881	Q9UQP3
ESAWTKPDGVKVIQQ	TCERG1	156	O14776
VPGIEKNWSTDLNIQ	TRABD	301	Q9H4I3
NGPVTQWKGTVLDQV	SPIN1	66	Q9Y657
GDEPLTQWKGTVLDQ	SPIN3	61	Q5JUX0
GDEPITQWKGTVLDQ	SPIN2B	61	Q9BPZ2
LQVSWTVDGPVQLVQ	ROBO3	686	Q96MS0
VSVGPLDQVWVIANK	TECPR1	1081	Q7Z6L1
VGWETTLENKELAPN	ZNF274	326	Q96GC6
TVTQNSVGLSWTVPE	TNXB	1786	P22105
IQELGVQESWSDGPK	TMEM102	41	Q8N9M5
LATLAQETGVWKNPV	ZNF292	151	O60281
GITSSGVVWEVKPKQ	VPS13C	3111	Q709C8
VKSTTVAVRGDQPSW	UNC13B	31	O14795
VQQVAVSPSGALLWK	TECPR2	851	O15040
QEAVTWKPGDNIVIA	PKHD1L1	2316	Q86WI1
DSGWIKVTAQPVERS	PKHD1L1	4056	Q86WI1
TWQTPDGNQVVRDKI	VSIG4	116	Q9Y279
SRVTESVKNIVPGWL	NUP153	41	P49790
KTSQGNAVNPVWEEE	PLCB1	716	Q9NQ66
KQIDTVAAEWPAQTN	CAD	901	P27708
KEPGVEDTEWSNTQT	VRK1	366	Q99986
VQVRGKEDPWNSITS	TIMM17A	81	Q99595
GQVWAGIPVQISEDK	ZNF112	141	Q9UJU3
RDGIWDVSVAKTQPV	WDR37	156	Q9Y2I8
IQLIPGSSSKWEEVQ	SLC30A4	376	O14863
QEQPVVLHTWTKESA	ZZEF1	1086	O43149
PTGIIIQNTDLVEWS	ERVK-19	351	Q9WJR5
IPTSANVQNAEGTKW	ZBTB38	641	Q8NAP3
DSWETLPGTQVTRKE	TRANK1	661	O15050
EVNATAVLWPSQVGT	SORCS1	906	Q8WY21
VSPLEWKGSVAILQQ	TGM7	251	Q96PF1
PQTGTWEIQVTAEDT	VWA7	576	Q9Y334
NETEDWSVTVIPGAK	TCTN2	76	Q96GX1
TSWTENQAGKIPEKV	SCG3	216	Q8WXD2
VSSPDWNKQQDIVGS	TNRC6A	941	Q8NDV7
VFVQGEKTWVPTSLQ	TFIP11	816	Q9UBB9
ANVTWIDQDGPVTVN	TMEM25	161	Q86YD3
VQELWSGTQKNVAPL	USP32	791	Q8NFA0
WKVGVTALQQAPAVD	WDR36	246	Q8NI36
PVQEIDGKAGTWNVE	ZSCAN23	181	Q3MJ62
VNGWEQVSPVSVDKV	VPS13D	2976	Q5THJ4
AKEEINWSAQTIGPD	NLRP14	91	Q86W24
KPNGETSTTTIRVWN	SLC8A3	116	P57103
IQEKTGNDWVPVTII	N4BP2L2	46	Q92802
PTNWIEGTQAVLRAK	NECTIN1	146	Q15223
IVEPHVTAVWGKNVS	NECTIN3	61	Q9NQS3